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ABSTRACT
The coelomic hemoglobin, dehaloperoxidase (DHP), from the sea worm
Amphitrite ornata, is a dual function oxygen-binding heme protein that also possesses a
significant peroxidase activity. As evolved from an ancient oxygen carrier globin, several
structural adaptations have enabled DHP to evolutionally gain significantly enhanced
peroxidase capability for self-protection while only minimally compromising its primary
function as an O2 carrier. To elucidate these adaptations, the peroxidase activities and O2
affinities of several DHP and sperm whale myoglobin (Mb) mutants have been prepared.
Several heme environmental structural factors that regulate the dual functions of DHP
have been found, providing insight into how DHP has gained significantly enhanced
enzymatic capability in an evolutional process for protection from its toxic living
environment without compromising its primary function as an O2 carrier. As to the
question how DHP interconverts the different oxidation states of heme required for its
hemoglobin (FeII) and peroxidase (FeIII) functions, a functional switching mechanism of
DHP has been proposed and carefully tested. Using stopped-flow methodology, the
H2O2-mediated conversion of oxy-Fe(II) DHP to the ferric state triggered by both
biologically relevant (TCP etc.) and non-relevant (ferrocyanide, etc.) compounds was
examined. It has been found that ferric heme ligands and spin-trapping reagents can
completely inhibit the TCP-triggered DHP functional switch, strongly supporting a
proposed mechanism involving substrate radicals (TCP⋅).
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To thoroughly study the structures and the functions of the diverse heme enzymes,
numerous heme iron model systems have been developed. Using the H93G Mb cavity
mutant, pioneered by Barrick, our laboratory has successfully prepared several model
heme complexes of defined structure. However, previous attempts to generate H93G
adducts with spectral properties resembling those of ferrous thiolate-ligated heme
proteins such as cytochrome P450 (P450) and C. fumago chloroperoxidase (CPO), were
not successful. In the second part of the dissertation, the first H93G Mb spectral models
for ferrous P450 and CPO have been generated with phosphine as the axial ligand. The
novel heme-phosphine complexes have been comprehensively characterized in their
ferric, ferrous and ferryl states with UV-visible absorption and MCD spectroscopy. The
data provide important insight into the unique spectral properties of thiolate-ligated heme
iron systems and further expand our extensive H93G Mb spectral model library.
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PART I
CHAPTER 1

Introduction to Part I:
Amphitrite ornata dehaloperoxidase (DHP): a dual function
hemoglobin/peroxidase

!
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Heme Proteins
About one quarter to one third of all proteins require metals to carry out their
functions [1]. Such proteins are generally termed as “metalloproteins”. Among them, the
heme-containing proteins are an important class that carries out a diverse range of
biological functions. One old and universal function of heme protein is the storage and
transport of oxygen molecule carried out by hemoglobin (Hb)/myoglobin (Mb), the blood
pigment. Some heme proteins are enzymes that catalyze the biological redox reactions
such as cytochromes P450s. Other heme proteins play essential roles in electron transfer
(e.g. cytochrome b5 and c) and signal transduction (e.g. CooA).
Most native heme proteins contain an iron-protoporphyrin IX group (heme b) with
the iron atom coordinated in the center by four pyrrole nitrogens and two vacant
coordination positions available for additional ligands (Figure 1.1). In heme proteins, the
heme prosthetic group is tethered to the protein backbone via a proximal amino acid
ligand that covalently binds to the heme iron. The functions of heme proteins depend
largely on the properties of the heme active site which is strongly influenced by three
factors: the iron oxidation and spin states, the nature of axial ligands coordinated to the
iron and the surrounding protein environment which affects the binding of the substrates.

Peroxidases
The heme enzymes that catalyze oxidation of organic substrates can be generally
dividend into two classes: oxygenases and peroxidases. The former uses O2 to oxidize
substrates (Eq. 1.1, showing reaction catalyzed by monooxygenase) and the latter uses
H2O2 (Eq. 1.2).

!

2

Figure 1.1. The structure of protoheme IX (iron protoporphyrin IX, heme b). The Greek
letters α to δ identify the sites of four each methane bridges and the Roman letters A to D
indicate the location of four pyrrole rings. An IUPAC numbering system is used here and
thus the carbons at 2, 3, 7, 8, 12, 13, 17 and 18 positions correspond to those at 1, 2, 3, 4,
5, 6, 7 and 8 positions in the classic Fischer numbering system.
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AH + O2 + 2H+ + 2e- ! AOH +H2O (1.1)
AH2 + H2O2 ! A + 2H2O (1.2)
Figure 1.2 elucidates the mechanism of action for peroxidases in comparison with
oxygenases. For peroxidases like horseradish peroxidase (HRP), the addition of H2O2 to
the ferric heme yields an unstable hydroperoxide adduct (commonly known as compound
0). Followed by heterolysis of the O-O bond, a high-valent oxidant intermediate called
compound I (Cpd I) is formed. Cpd I is an O=FeIV cation radical with an odd electron
located on the porphyrin (porphyrin π cation radical). In some peroxidases, the Cpd I
transforms to an equivalent oxidant traditionally called Cpd ES with the odd electron
relocated to a nearby Trp or Tyr. The CpdI/CpdES oxidizes the organic substrate and
returns to ferric state, which is a process consisting of two sequential one-electron steps
for peroxidases involving another ferryl intermediate named Cpd II (O=FeIV) (not
shown). The organic substrates were oxidized to radicals (AH•) that either
disproportionate (Eq. 1.3) or dimerize (Eq. 1.4). By comparison, oxygenases like
cytochrome P450 follow a more complicated catalytic mechanism involving an electron
transfer system to generate Cpd I, which is again the active enzyme oxidant.
AH• + AH• ! AH2 + A (1.3)
AH• + AH• ! HA-AH (1.4)
Typical peroxidases contains a single polypeptide of 30~50 kDa and a heme b
prosthetic group. Based on the sequence homologies and crystal structures, peroxidases
are generally divided into two classes: mammalian and nonmammalian types. Examples
for mammalian peroxidases are myeloperoxidases (MPO) in human neutrophil,
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Oxygenase
Fe(III)
Ferric

O2
e-

O

O

O

O

Fe(III)
Superoxide

Fe(II)
Oxyferrous

Peroxidase

+ H2O2

H+

2H+ + e-

O

OH

Fe(III)
Hydroperoxide

H+
H2O

O
Fe(IV)
Active oxidant

Figure 1.2. Activation of O2 and H2O2 by monooxygenase and peroxidase, respectively,
both results in active oxidant known as compound I (Adapted from reference [2]).
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lactoperoxidase (LPO) in milk and thyroid peroxidase. The non-mamalian peroxidases
have been found in yeast (e.g. cytochrome c peroxidase), fungi (e.g. lignin peroxidase) as
well as plants (e.g. horseradish peroxidase). At present, over 700 peroxidase structures
are available in the Protein Data Bank (PDB). The overall foldings and active site
structures are well conserved (except for the two recently discovered globin peroxidases
Amphitrite ornata dehaloperoxidase and Notomastus lobatus chloroperoidase).
The crystal structure of the yeast cytochrome c peroxidase (CCP) was the first heme
peroxidase to be solved by X-ray crystallography (Figure 1.3) [3]. A close-up
examination (Figure 1.3, right panel) reveals a charge relay network involving the
proximal Asp/His and the distal His/Arg groups. Poulos and Kraut proposed a “pushpull” mechanism for the formation of peroxidase Cpd I, which is the most crucial step in
the peroxidase catalytic path [4]. As shown in Figure 1.4, the proximal ligand His175
forms a hydrogen bond with the nearby Asp235 carboxylate group, which gives the
proximal His partially deprotonated histidinate character. This provides an electron
“push” to the heme iron. On the distal side, the cationic Arg48 provides a “pull” effect by
dispersing the developing negative charge on the outer O atom of the bound H2O2. The
adjacent His52 also contributes as a general acid/base catalyst, deprotonating the inner O
and transferring the proton to the outer O. The “push” and “pull” machinery works
together to heterolytically cleave the O-O bond in heme-bound H2O2, resulting in
formation of Cpd I with release of a water molecule.

Globins
Globins are a group of heme proteins that reversibly bind dioxygen. The structure of
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Figure 1.3. X-ray crystal structure of yeast CCP with the active site enlarged on the right
(PDB 2CYP, also see reference [3]).
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Figure 1.7. “Push-Pull” paradigm for heterolytic O-O bond cleavage in His-ligated

Figure 1.4. “Push-Pull” paradigm for heterolytic O-O bond cleavage in peroxidases
(adapted fromperoxidases
reference[adapted
[5]). from reference (13)].

14
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a globin consists of several alpha helixes that form an overall globular shape and a heme
cofactor whose center iron is where the O2 binds. Myoglobins (Mb) are found in muscle
cells and serve as an O2 reservoir. Hemoglobins (Hb) circulate throughout the organisms,
delivering O2 to tissues for respiration. The first X-ray structure of globin was solved in
1958 by John Kendrew for sperm whale Mb [6]. It is a monomer consisting of 154 amino
acids. Hb typically contains multiple subunits that may bind O2 cooperatively, i.e. the O2
affinity increases along with the saturation of O2 due to the conformational changes upon
ligand-binding and the dynamic correlations between subunits.
The globin function, i.e. reversible O2 binding, is regulated by several factors such
as heme iron oxidation state, reduction potential and the amino acids surrounding heme
[7-12]. Only ferrous heme (FeII) binds O2, ferric heme (FeIII) does not. Therefore globins
generally possess more positive redox potentials [100 ± 5 mV vs. standard hydrogen
electrode (SHE) [13]] favoring the stable ferrous state. In contrast, the redox potential for
peroxidases are typically negative [13]. Another important regulator of O2 binding is the
distal His that has been found to interact with the bound O2 through an H-bond in most
globins [7, 14].
Besides the major O2 carrier function, some Mbs exhibit peroxidase-like activities
under oxidative conditions when the heme iron is oxidized to theferric state [15, 16].
Ferric Mb reacts with H2O2 yielding high-valent heme species (Cpds I and II) that oxidize
the biological molecules involved in oxidative stress reactions [17-20]. The peroxidase
catalytic path of Mb is generally analogous to that of a typical peroxidase [21-23]. It has
also been reported that Mb also has nitrate reductase activity in response to hypoxia in
mammalian cells, which further broadens the functional versatility of globins [24].
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Dehaloperoxidase from A. ornata
In 1977, a coelomic Hb was discovered as the most abundant protein in the sea
annelid Amphitrite ornata [25]. The worm was found buried in coastal mud with a
reddish color throughout the body (Figure 1.5). Later in 1996, the same protein was
rediscovered as a dehaloperoxidase enzyme that detoxifies halophenolic metabolites
secreted by other marine cohabiters such as Notamastus lubatus (eq. 1.4) [26]. The dual
functional Hb was then named as dehaloperoixdase (DHP) and was the first catalytically
active globin [27]. Two genes (dphA and dphB) have been found encoding DHPA and
DHPB respectively [28]. The two isomers only differ at five amino acids.

(1.4)
The crystal structure of DHP A was determined by Lebioda and coworkers in 2000
[29]. DHP is a dimer containing two identical, but functionally non-cooperative subunits
(Mr = 15,590). The typical globin-fold of DHP is analogous to that of SW Mb while
distinct from those of traditional peroxidases such as HRP (Figure 1.6). HRP is twice as
large as DHP and the two proteins have distinctly different heme environments: HRP has
the heme buried inside the protein while the heme in DHP is more exposed to the solvent.
Despite these differences, Mb, DHP and HRP all share a common heme active site
construct consisting of a heme, a distal His and a proximal His (Figure 1.7). Close
examination reveals subtle differences among the three. First of all, the distal His is much
further (6.0 Å) from the heme iron in HRP than that in sperm whale Mb (4.6 Å). This
longer distance favors H2O2 heterolysis over O2 biding. The DHP has an intermediate
!
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Figuer 1.5 The sea worm Amphitrite ornata
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Figure 1.6 Structural comparison of dehaloperoxidase hemoglobin (DHP, PDB 2QFK),
sperm whale myoglobin (SWMb, PDB 1A6G) and horseradish peroxidase (HRP, PDB
2ATJ) [30].
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Figure 1.7 A comparison of the active sites of sperm whale Mb (pink), DHP (blue) and
horseradish peroxidase (green) (adapted from reference [31]).
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distal His Nε-Fe distance (5.4 Å) which to accomplish both O2 binding and H2O2
heterolysis [27]. On the proximal side, the rotational angle of proximal His in DHP is
about 60° rotated clockwise from that in Mb, resulting in new interaction of proximal His
with peptide carbonyl group that provides a weak electron push [27]. Nevertheless, DHP
lacks a strong proximal “push” effect that has been seen in typical peroxidases (see
Figure 1.7) [32]. The proximal His in DHP is neutral like other globins as indicated by
extensive spectroscopic data [33]. The significantly enhanced (> 250-fold) peroxidase
activity of DHP compared with Mb is the outcome of both distal and proximal side heme
environment adaptations during the evolution of DHP from an ancient O2 carrier [27].
The DHP catalytic cycle involves two consecutive one-electron oxidations of the
halophenolic substrates by Cpd ES/Cpd II, yielding halophenoxyl radicals (Figure 1.8).
The radicals then undergo further oxidation and hydration to form the final quinone
product [34, 35]. The substrate binding follows the traditional peroxidase order, i.e., H2O2
binds prior to organic substrate as suggested by extensive rapid-scan stopped flow
spectroscopic studies [36].
A unique structural feature in DHP is the great flexibility of distal His, which has
two conformations at room temperature. The “closed” conformation resembles that of
sperm whale Mb while the “open” conformation has the distal His swung out and
exposed to the solvent (Figure 1.9) [29]. The crystal structure also suggested that the
“open” conformation associates with the absence of distal H2O while the “closed” His
forms a hydrogen bond with a H2O molecule that coordinates to the heme iron. As the
distal His is involved in the binding/activation of H2O2 as well as in the binding of O2, it
controls both peroxidase and globin functions of DHP. The halophenolic substrate
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Figure 1.8. Proposed enzymatic mechanism for the dehalogenation reaction of
trihalophenol catalyzed by three peroxidases: DHP, HRP and chloroperoxidase (CPO).
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Figure 1.9. Superposition of heme active sites of Mb (blue) and DHP A (Pink) showing
the two conformations of DHP distal His [31].
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binding can modify the distal His conformation by binding internally inside the distal
pocket or externally at the heme edge. As indicated by both X-ray crystallographic [29,
37] and resonance Raman spectroscopic [38] studies, small halophenols like 4bromophenol (4-BP) bind internally, forcing the distal His to an “open” position and thus
inhibiting the catalytic activity of DHP. Relatively bigger halophenols, such as 2,4,6trichlorophenol (TCP), are found binding either deep inside or at the entrance of the distal
pocket [39]. The latter is proposed as the binding site of substrate TCP to DHP Cpd I
[39].
DHP has the highest reduction potential [~ 205 mV [40]] among the globins so its
oxyferrous state is especially stable. However, this is not a favorable characteristic for a
peroxidase because the catalytic cycle of peroxidases start from the ferric state and
oxyferrous (also known as Cpd III) DHP is a catalytically inactive species. A paradoxical
question as to how the O2 carrier state of DHP switches to its enzymatically active ferric
state needs to be addressed. There is evidence that substrate trihalophenol plays an
important role in DHP functional switching [41, 42].
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CHAPTER 2

Influence of Heme Environment Structure on Dioxygen Affinity for the
Dual Function Amphitrite ornata Hemoglobin/Dehaloperoxidase. Insights
into the Evolutional Structure-Function Adaptations1

1

Sun, S., Sono, M., Wang, C., Du, J., Lebioda, L., and Dawson, J. H. (2014) Arch.

Biochem. Biophys. 545: 108-115. Preprinted here with permission of publisher.
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ABSTRACT
Sea worm, Amphitrite ornata, has evolved its globin (an O2 carrier) also to serves as a
dehaloperoxidase (DHP) to detoxify haloaromatic pollutants generated by competing
species. A previous mutagenesis study by our groups on both DHP and sperm whale
myoglobin (SW Mb) revealed some structural factors that influence the dehaloperoxidase
activities (significantly lower for Mb) of both proteins. Using an isocyanide/O2 partition
constant measurement method in this study, we have examined the effects of these
structural factors on the O2 equilibrium constants (KO2) of DHP, SW Mb, and their
mutants. A clear trend of decreasing O2 affinity and increasing catalytic activity along
with the increase in the distal His Nε–heme iron distance is observed. An H93K/T95H
Mb double mutant mimicking the DHP proximal His positioning exhibited markedly
enhanced O2 affinity, confirming the essential effect of proximal His rotation on the
globin function of DHP. For DHP, the L100F, T56G and M86E variants showed the
effects of distal volume, distal His flexibility and proximal electronic push, respectively,
on the O2 affinity. This study provides insights into how DHP has evolved its heme
environment to gain significantly enhanced peroxidase capability without compromising
its primary function as an O2 carrier.!

Keywords: Amphitrite ornata dehaloperoxidase (DHP); sperm whale myoglobin (Mb);
O2 affinity; heme environment mutants; evolutional structure-function adaptations.
!
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INTRODUCTION
When the coelomic hemoglobin from the terebellid polychaete Amphitrite ornata
was discovered in the 1970’s [1], its peroxidase activity was unknown. In the 1990’s, a
dehaloperoxidase (DHP) enzyme was discovered in the same sea worm that detoxifies
halophenols in the tidal sediments where it grows. It is the coelomic hemoglobin that
carries out the DHP activity. Traditional heme-containing peroxidases [2] and globins
[hemoglobins (Hbs) and myoglobins (Mbs)] [3] have distinct physiological functions:
catalyzing the H2O2–dependent oxidation versus the reversible binding of dioxygen (O2).
These protein superfamilies have entirely different folds and are not evolutionally related.
However, both contain a heme unit bound to the protein scaffold through a proximal
histidine that serves as a coordinating ligand to the heme iron, leaving the distal side of
the heme capable of binding peroxide (peroxidase) or O2 (globin). DHP, which is the
most abundant protein in Amphitrite ornata, carries out both functions as a globin that
transports and stores O2 and as a peroxidase that detoxifies trihalophenol substrates
[2,4,6-TXP (X = F, Cl, Br)] (Scheme 1) [4]. Its structure (with very similar folds to Mb
[5], Figure 2.1 A) and amino acid sequence indicate that DHP have evolved from an
ancient oxygen carrier globin [6].
OH
Y

O
Y

Y
+ H2O2

X

Y

DHP

+ H2O + HX

Substrates:
X = F, Cl, Br
Y = F, Cl, Br, CH3
Inhibitors: X= Br, I; Y = H

(1)
(2.1)

O

It has been a subject of intense investigations to probe what structural factors enable
a globin to obtain peroxidase activity while still maintaining the O2 carrier function [7-9].
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Figure 2.1. Ferric DHP (pink, lighter color) and sperm whale Mb (blue, darker color) X-ray
structures alignments for entire peptide folds (A) and heme and its environmental amino acids
that are subject of this study (B) created by superposing the common heme ring atoms. PDB
accession codes are 1EW6 (DHP) and 1A6K (Mb). Note that, in panel A, amino acid side
chains are omitted; in panel B, for the distal His-55 of DHP, two positions (open and closed)
are shown. This figure was prepared using Pymol.
!
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In a recent study by our group, a mutagenesis approach was utilized to investigate several
structural factors that influence the peroxidase activity of DHP [10]. For example, the
importance of the proper position of the distal His relative to the heme iron has been
found crucial for the peroxidase activity of DHP [10]. DHP has an intermediate distal His
Nε-Fe distance (5.4 – 5.5 Å) compared to that in Mb (4.3 – 4.5 Å) and horseradish
peroxidase (HRP) (~6.0 Å) and its dehaloperoxidase activity is also the intermediate of
the three [10-12]. This position of the distal His in DHP appears to be convenient for
carrying out both O2 binding in the ferrous protein and acid-base catalysis for O-O bond
cleavage of the heme iron-bound peroxide by ferric DHP. Several Mb mutants with an
elongated distal His-Fe distance (G65T, G65I and F43H/H64L Mb) showed enhanced
dehalogenation abilities [10]. The reversible O2 binding property might also be affected
by these mutations since the bound O2 in Mb is stabilized by H-bonding to the distal His
[13-15]. Another distal side factor that could regulate O2 binding in Mb is the steric effect
of Ile107 (Figure 2.1 B). Replacing I107 in both human and sperm whale (SW) Mbs with
a bulky Phe has been shown to increase the O2 affinity [16, 17]. In our previous
mutagenesis study, a L100F DHP variant exhibited a dehaloperoxidase activity that is
similar to that of the wild type [10].
Besides the distal effect, a charge relay mechanism from the proximal side may also
affect the dual functions of DHP. A M86E mutation in DHP introduces a negatively
charged residue nearby the originally neutral proximal His and expectedly enhances the
peroxidase activity of DHP [10, 18]. This mutation could also modify the O2 affinity
since the charge relay system could stabilize ligand binding by enhancing the π-backbonding from the iron to the ligand [19, 20]. Another proximal factor that is crucial for
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the peroxidase activity of DHP (much higher than that of Mb) is a roughly 60° rotation of
the proximal His imidazole ring compared with Mb [5, 10] (Figure 2.1 B). The Mb
double mutant (H93K/T95H) that mimics the rotational position of the proximal His in
DHP become a much better peroxidase than wild type Mb [10]. Since the rotation of
proximal His has also been seen to significantly affect O2 affinity in many other heme
proteins [21, 22], similar effects of the proximal His rotation on the reversible O2 binding
property of DHP are expected.
In this study, the structural factors that influence the dehaloperoxidase acitivities of
DHP (previous study [10]) have been examined for their influence on the O2-binding
function of DHP. Both heme distal and proximal side structural and electronic factors that
influence the O2-binding function of DHP have been examined to elucidate how DHP has
altered its heme environment to evolutionally gain significantly enhanced peroxidase
capability for self-protection without compromising its primary function as an O2 carrier.
In addition, the effects of substrate 2,4,6-trichlorophenol (TCP) and inhibitor 4bromophenol (4-BP) binding on the O2 affinities have also been evaluated for both wild
type and a mutant DHP (T56G, designed with an increased flexibility of distal His) to
probe their possible role(s) in functional switching of DHP from an O2 carrier (ferrous
state) to a peroxidase (ferric state).

!

MATERIALS AND METHODS
Materials.
All reagents and biochemicals were purchased from Aldrich, ACROS, or Fisher and
used without further purification except for potassium ferricyanide, which was
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recrystallized from water. H2O2 stock (10 mM) in deionized water was prepared daily
from a 30% commercial stock solution and the concentrations were routinely verified by
UV-visible (UV-Vis) spectroscopic analysis at 240 nm (ε240 = 39.4 M-1cm-1) [23].
Trichlorophenol (TCP) and 4-bromophenol (4-BP) stock solutions (100 mM) were
freshly prepared in a 50/50 (v/v) ethanol/deionized water mixture.
Mutagenesis and Sample Preparation.
The expression vectors (pUC 19) for wild-type and F43H/H64L sperm whale Mb
were gifts from Prof. Yoshihito Watanabe (Nagoya University). The procedures of
expression and purification for sperm whale Mb mutants (pUC 19-G65T, -G65I and –
H93K/T95H) and 6×His-taggged DHP A mutants (pET 16b-T56G and M86E) can be
found in our previous mutagenesis study [10]. The isolated Mb and DHP proteins were
completely oxidized to the ferric state by addition of a few crystals of potassium
ferricyanide (Fluka) followed by gel-filtration column chromatography in 100 mM
potassium phosphate (pH 5) at 4 °C. Protein concentrations were determined by the
pyridine hemochromogen method (ε555 = 34.4 M−1 cm−1) [24]. The oxyferrous protein
was formed by addition of a slight excess of sodium dithionite to the ferric protein,
followed by aerobic Bio-Gel P6DG (Bio-Rad) desalting column with 100 mM potassium
phosphate buffer (pH 7) at 4 °C. Deoxyferrous protein samples were prepared in a rubber
septum-sealed cuvette by addition of a small amount of solid sodium dithionite to a
thoroughly degassed ferric sample in 100 mM potassium phosphate buffer (pH 7) at 4 °C.
O2 dissociation equilibrium constant (KO2) determination.
O2 dissociation equilibrium constants (KO2) of DHP (or Mb) were determined by the
method used by Makino and Yamazaki [25] by first measuring a partition constants (KP)
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for the replacement of the bound O2 in oxyferrous protein by isocyanide ligand (L) (Eq.
2.2) and then a dissociation constant (KL) for an isocyanide bound deoxyferrous protein
(Eq. 2.3).
Kp

DHP-O2 + L

DHP-L + O2

(2.2)

KP = [DHP-L] [O2] / [DHP-O2] [L]
= {[DHP] [O2] / [DHP-O2]} / {[DHP] [L] / [DHP-L]}
= KO2 / KL
KO2 and KL are defined as follows:
DHP + L

KL

DHP-L

(2.3)

KL = [DHP] [L] / [DHP-L]

(2.4)

DHP + O2

(2.5)

KO2 DHP-O2

Thus, from Eq. (2)
KO2 = KL × Kp

(2.6)

Kp and KL(O2) were determined by step-wise isocyanide titration of oxyferrous (~ 10
µM) and deoxyferrous (~ 3 µM) DHP/Mb, respectively, in 100 mM potassium phosphate
buffer (pH 7.0 or 9.0 for one particular case of a Mb mutant) at 4 oC (or ~22 oC for a few
cases). Two kinds of isocyanide ligands were used in the titration experiments depending
on proper affinity ranges between the values (Kd) for the O2-bound (Kd = 10-5 – 10-3 M)
and deoxyferrous states bound (Kd = ~10-6 M) of titrated proteins (if the isocyanide
affinity is too high or too low, its accurate determination would be difficult or practically
impossible because of large errors or ligand solubility limits, respectively): Isopropyl
isocyanide (IPIC) was used for titrations of wt-Mb and H93K/T95H Mb; t-butyl
isocyanide (TBIC) was used for titrations of other Mb mutants and all DHPs. For the
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titration of oxyferrous proteins, 4 mM ascorbate (pH adjusted to a neutral value) and
bovine liver catalase (0.1 – 0.5 µM based on heme) were added to the sample to prevent
autoxidation of the heme and ascorbate-caused undesirable reactions [26]. To help
maintain the O2 concentration constant throughout the titration (< 3 h), the sample were
bubbled with air through a Pasteur pipette after each addition of ligand. The titration of
deoxyferrous proteins were carried out anaerobically in the presence of slight excess of
sodium dithionite in a rubber septum-sealed cuvette and the isocyanide ligands were
added in a step-wise manner using a gas-tight microliter syringe.
Titration spectra were analyzed using a simple biomolecular association scheme and
the plots of absorbance change vs. ligand concentration were analyzed by a hyperbolic
regression fit of a saturation plot (absorbance change vs. ligand concentration), giving the
values of Kp and KL. Three or more sets of Kp and KL were obtained for each titration to
calculate the final KO2 using Eq. 2.4. The O2 concentrations were considered as 400 µM at
4 °C and 270 µM at room temperature (~22 °C) [27, 28].
Peroxidase Activity Assay
UV-Vis absorption spectroscopy was used to measure the peroxidase activity of
DHP at 4 oC in100 mM potassium phosphate buffer (pH 7.0). TCP were added to the
ferric enzyme (~3 µM) before addition of hydrogen peroxide to initiate the reactions in a
0.5-cm cuvette. The turnover number (kcat) can be measured by monitoring the change in
absorbance at 272 nm for the appearance of quinone products (ε272 = 14 mM-1cm-1) [29].
The kcat values were determined by calculating the velocity (vo) from the initial linear
portion of the trace at 272 nm as a function of H2O2 concentration with a fixed [TCP],
followed by a graphical calculation (hyperbolic curve fitting) of a vo value at infinite
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[H2O2] to obtain a vmax value and then by dividing the vmax by the enzyme concentration
(kcat = vmax/[DHP]). For each set of reaction conditions, 10 replicates were performed and
then averaged to determine the velocity at the varying [H2O2] (typically 20 ~ 480 µM)
and fixed [TCP] (500 µM).
Spectroscopic Techniques.
UV-Vis absorption spectra were recorded with a Cary 400 spectrophotometer
interfaced to a Dell PC. Magnetic circular dichroism (MCD) spectra were measured with
a magnetic field strength of 1.41 T by using a JASCO J815 spectropolarimeter equipped
with a JASCO MCD-1B electromagnet and interfaced with a Gateway PC through a
JASCO IF-815-2 interface unit. Data acquisition and manipulation were carried out as
previously described [30].
Crystallography.
The L100F variant of DHP was crystallized in the oxyferrous form (as purified)
using the vapor diffusion method in hanging-drop set-up. The protein dissolved in 20 mM
sodium cacodylate pH 6.5 was concentrated to 10 mg/ml. The crystals were grown from
solutions containing 0.2 M ammonium sulfate and 26-34% polyethylene glycol 4000, as
previously reported for other DHP mutants [31]. The data set was collected at SERCAT
22ID beamline at the Advanced Photon Source (APS) in the Argonne National
Laboratory. The data were indexed, integrated and scaled with the HKL2000 software
package. Data collection and processing statistics are listed in Table 2.6. The structure of
L100F•O2 was determined using molecular replacement with the Phaser program from
the CCP4 suite of program using the wt-DHP structure (PDB entry 1EW6) as the initial
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model. Structure rebuilding was carried out using Coot and Turbo and structure
refinement and map calculation were performed using Refmac5 from the CCP4 [31].

RESULTS
Representative TBIC titration spectra for oxyferrous and deoxyferrous DHP are
shown in Figure 2.2, A and B, respectively. Analyses of these titrations (shown in the
insets) yield KL(O2) (= [O2] / Kp) and KL values of 0.46 mM and 3.63 µM, respectively, at
pH 7.0 and 4 °C (see Materials and Methods section). The KO2 value of 3.23 µM (= KL ×
Kp) [3.23 ± 0.37 µM, Table 2.1] is calculated from these values (Eq. 2.6). To evaluate
the accuracy of our isocyanide/O2 partition constant measurements, we have also
determined the KO2 values of SW Mb and DHP at ~22 °C using this method (Table 2.5).
The results for Mb agree with previously reported values [3, 25]. Our KO2 value for DHP
(7.70 ± 0.45 µM at ~22 °C) is somewhat larger than the one reported by Weber et al. at
20 °C [1] [KO2 = 5.1 µM, converted from 2.8 mm Hg by KO2 (µM) = 1.82 × KO2 (mm
Hg), (Section 7.4 in [3]). A probable reason for this difference may be that the KO2 value
reported by Weber et al. [1] was likely for a mixture of the two isozymes, DHP A and B
while this O2 affinity study is for DHP A as an extension of our previous investigations
on DHP A and its mutants that we have prepared [10]. DHP A and DHP B encoded by
two separate genes. They have very similar structures while only differing in five amino
acids [4, 32]. DHP B has an almost two-fold higher O2 affinity than DHP A (Sun, S.,
Wang, C., Sono, M., Lebioda, L., Dawson, J.H., unpublished result).
Tables 2.1-2.4 show the KO2 values measured (in this study) as well as the
dehaloperoxidase activities (kcat) for Mb mutants (previous study [10]) and wt-DHP and
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Figure 2.2. UV-visible absorption spectral changes on TBIC titrations of oxyferrous DHP (A)
and deoxyferrous DHP (B) in 0.1 M potassium phosphate buffer, pH 7.0 at 4 °C. Oxyferrous
DHP (2.31 mM) and deoxyferrous DHP (3.34 mM) were titrated by incremental additions of
0.03, 0.06, 0.11, 0.22, 0.50, 1.05, 2.14, 4.24 mM (oxyferrous DHP) and 0.80, 1.60, 2.40, 3.18,
3.98, 7.95, 15.90, 31.74, 190.14 mM TBIC (deoxyferrous DHP). Vertical arrows indicate the
directions of absorbance change. Hyperbolic saturation plot (solid circle) and its regression fit
(solid line) of the titration data are shown in the insets, where the peak-to-trough absorbance
change in difference spectra (not shown) (ΔΔA432-412 = ΔA432 - ΔA412, ΔΔA430-414 = ΔA430 ΔA414) are plotted as function of TBIC concentration ([TBIC]). In B, [TBIC] values used are
[protein-free TBIC] (= [total TBIC] – [protein-bound TBIC]), while in A, [total TBIC] values
are used since [protein-free TBIC] ≈ [total TBIC].
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its mutants (new larger values by 1.1 – 3.1 times obtained in this study with higher [TCP]
= 500 µM vs.150 µM in the previous study [10]). The resulting kcat values for G65T,
G65I and F43H/H64L Mb mutants increased along with the distal His Nε – heme iron
distance (Table 2.1) [10]. Conversely, the KO2 values measured in this study show the
opposite trend, i.e., their O2 affinities decrease as the distal His Nε – heme iron distance
increases.
The L100F DHP variant, in which the distal side Leu100 is replaced with a bulkier
Phe group, has only a subtle effect in the turnover numbers [10], but exhibits a 3-fold
higher O2 affinity than the wild type (Table 2.2). The crystal structure of the L100F•O2
complex was determined (Figure 2.3) and its parameters and refinement statistics are
listed in Table 2.6. The structure of the L100F•O2 complex shows that Phe100, which is
located at the back of the cavity, does not form contacts with the bound dioxygen
molecule nor with the distal histidine (Figure 2.3).
Two proximal side mutants, one for DHP and the other for Mb, have also been
studied. The O2 affinity of M86E DHP, in which a negatively-charged Glu group is
introduced close to the proximal His89, shows a significant increase by about 5-fold
while at the same time displacing an approximately three-fold increase in dehalogenase
activity (Table 2.2), Table 2.3 lists the KO2 value for H93K/T95H Mb, which is design to
mimic the proximal His plane of DHP that is rotated by 60° compared with that of Mb
(see Discussion), measured at pH 9.0 (to avoid enhanced autoxidation of its oxy-complex
at pH 7.0). It should be noted that the O2 affinities of both DHP [1] and Mb[3] are pHindependent (between pH 6 and 9), i.e., neither protein exhibits a Bohr effect. This Mb
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Table 2.1. O2 affinities of SW Mbs (wt and mutants) and wt-DHP (this study) in 100 mM
potassium phosphate buffer (pH 7) at 4 °C and their turnover numbers (kcat, previous
study [10]) for the oxidative dechlorination with 150 µM TCP and varying H2O2
concentration in 50 mM sodium acetate buffer (pH 5.4) (Mbs) or 50 mM sodium citrate
buffer (pH 5.4) (DHP) at 4 °C.

Fe-His55 Nε kcat (min-1)
distance (Å)b 4 °C, pH 5.4a,c

Protein

KO2 (µM)
4 °C, pH 7.0a

wt-Mb

0.27 ± 0.01 (1.0)

4.3

19.0 ± 1.7 (1.0)

G65T Mb

0.39 ± 0.05 (1.4)

4.6

92.0 ± 7.0 (4.8)

G65I Mb

1.34 ± 0.21 (5.0)

5.1

138 ± 10 (7.3)

F43H/H64L Mb

6.12 ± 0.60 (23)

5.4

161 ± 9

(8.5)

wt-DHP

3.23 ± 0.37 (12)

5.4

243 ± 3

(13)

a

The values in parentheses are relative KO2 or kcat vs. those of wt-Mb.
PDB accession codes for metaqua (H2O-ligated ferric heme) structures of proteins listed
in this table: wt-Mb (1A6K), G65T Mb (3O89), G65I Mb (3SDN), F43H/H64L Mb
(1OFK) and DHP (1EW6).
c
From ref [10].
b
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Table 2.2. O2 affinities of DHPs and their turnover numbers for the oxidative
dechlorination with 500 µM TCP and varying H2O2 concentration in 100 mM potassium
phosphate buffer (pH 7) at 4 °C.

kcat (min-1)
4 °C, pH 7.0 a, b

Protein

KO2 (µM)
4 °C, pH 7.0 a

wt-DHP

3.23 ± 0.37 (1.0)

25 ± 1.0 (1.0)

L100F DHP

1.03 ± 0.07 (1/3.1)

20 ± 1.7 (0.8)

M86E DHP

0.64 ± 0.08 (1/5.1)

78 ± 5.7 (3.1)

a

The values in parentheses are relative KO2 or kcat vs. those of wt-DHP.
The kcat values in this table that were obtained in this study using 500 µM TCP are
larger than the corresponding values determined with 150 µM TCP in the previous study
[10] by the factors of ~3.2 (wt-DHP), ~3.3 (L100F DHP) and ~1.1 (M86E DHP).
b
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!!!!!!!!!!!!!!!!!!(A)!

!!!!!!!!!!!!!!!!!!!(B)!

Figure 2.3. Stereoview of the structure (A) and electron densities (B) of the L100F DHP
A•O2 complex and its heme distal side environment. Phe100 is located deep in the distal
pocket and does not form contacts with dioxygen or His55. Two positions of His55 are
stabilized through hydrogen bonding with O2 and a heme propionate. The final 2FoFc map
is contoured at a 1 σ level. Somwhat broaden density of the distal O2 atom of the dioxygen
molecule may be relatedd to the disorder of His55. This figure was prepared using Pymol
and Turbo.
!
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Table 2.3. O2 affinities of SW wt-Mb and its H93K/T95H mutant (this study) in 100 mM
potassium phosphate (pH 9) at 4 °C and their turnover numbers (previous study [10]) for
the oxidative dechlorination with 150 µM TCP and varying H2O2 concentration in 50
mM sodium acetate buffer (pH 5.4) at 4 °C.

a

!

kcat (min-1)
4 °C, pH 5.4 a,b

Protein

KO2 (µM)
4 °C, pH 9.0a

wt-Mb

0.33 ± 0.02 (1.0)

19.0 ± 1.7 (1.0)

H93K/T95H Mb

0.015 ± 0.003 (1/22)

104 ± 13 (5.5)

The values in parentheses are relative KO2 or kcat vs. those of wt-Mb. b From ref [10].
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mutant exhibits ~ 20-fold higher O2 affinity than that of wt-Mb, along with ~ 50-fold
increase in peroxidase activity as reported previously [10].
For the T56G DHP mutant that designed to increase the flexibility of distal His, its
O2 affinity was measured both in the absence and presence of TCP/4BP. In the absence of
TCP/4-BP, T56G DHP has ~ 3.4-fold higher kcat and ~2.4-fold lower O2 affinity than the
wt-DHP (Table 2.4). Upon addition of 2 mM TCP or 4BP, O2 affinity of T56G DHP
becomes almost two-fold higher and ~1.5-fold lower, respectively (Table 2.4). In
contrast, addition of either 2 mM TCP or 4-BP barely altered the KO2 of wt-DHP (Table
2.4). Note that none of the KL values in Table 2.4 for the affinity of isocyanide ligand
used in the O2 affinity measurements are significantly affected by added TCP or 4-BP.
Figure 2.4 (plotted using data in Table 2.7) shows the concentration-dependency of the
effect of TCP on the O2 affinity of T56G DHP.
To understand the different effects of TCP on the O2 affinity of T56G DHP vs. wtDHP, the absorption and MCD spectra of TCP-bound ferric T56G DHP were recorded in
this study (Figure 2.6, red solid line), which closely resemble those of the acetate
complex of ferric wt-DHP (at pH 5.4, black dotted line in Figure 2.6) and Mb (at pH 7,
blue dashed line in Figure 2.6), both reported previously [10].

DISCUSSION
Here, we consider several steric and electronic factors that influence the O2 affinities
of DHP as well as Mb using the wild-type proteins and several mutants in the context of
evolutional heme environment structural adaptations of DHP to its dual functions. Since
we can only see the consequence (outcome) of evolutions in the functions and structure
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Table 2.4. O2 affinities (KO2) of wt-DHP and T56G DHP and turnover numbers (kcat ) for
the oxidative dechlorination with 500 µM TCP and varying H2O2 concentration (100 mM
potassium phosphate buffer, pH 7.0, 4 °C). All the values were determined in this study.
See text for the definitions of KL (isocyanide equilibrium dissociation constant) and KP
(O2/isocyanide partition constant) for deoxyferrous DHP.

Protein

kcat (min-1)

KO2 (µM)

w/o TCP
wtDHP

25.0 ± 1.0
+ TCP (2 mM)

3.47 ± 0.48

Kp

0.93 ± 0.06

KL

3.60 ± 0.19

Kp

0.98 ± 0.02

KL

3.17 ± 0.32

Kp

0.93 ± 0.15

3.53 ± 0.24

2.95 ± 0.04

w/o TCP / 4-BP

KL

0.45 ± 0.03

Kp

17.40 ± 0.92

KL

0.43 ± 0.04

7.83 ± 0.83

86.4 ± 6.5
+ TCP (2 mM)

4.23 ± 0.52

+ 4-BP (2 mM)

Kp

9.83 ± 0.82

KL

0.47 ± 0.05

Kp

25.00 ± 2.83

11.73 ± 0.89

!
!

!

KL
3.23 ± 0.37

+ 4-BP (2 mM)

T56G
DHP

KL (µM) and Kp

40

9
T56G DHP
wt-DHP

8

KO2 (µM)

7
6
5
4
3
2
0.0

0.5

1.0
1.5
[TCP] (mM)

2.0

Figure 2.4. Effects of TCP concentration (0 – 2 mM) on the O2 affinities (KO2 in
µM) of T56G DHP vs. wt-DHP in 100 mM potassium phosphate buffer (pH 7.0) at 4
°C. The solid line for T56G DHP is drawn by fitting the four data points to a
hyperbolic regression curve that yields KO2 = 3.4 µM at infinite [TCP] and [TCP] =
0.68 mM for a half maximum change in KO2 value. The dashed line for wt-DHP is
drawn as a straight horizontal line at KO2 = 3.4 µM.
!

!

41

of wt-DHP, we use here Mb, and in some cases, DHP itself and their heme environmental
mutants in an effort to trace back and interpret likely function-related structural
evolutions in DHP. We note although the effects of such mutations within a given system
(Mb or DHP) may be applicable to the other system, the actual KO2 values of the two
systems may not necessarily be directly comparable.
Effects of Fe-Distal His55 Nε Distance
DHPA has an almost 10- (or 6-) fold lower O2 affinity (i.e., higher KO2 value) than
that of SW Mb [3, 25] (or horse heart Mb [3, 33]). This is likely the result of a
compromise involved in obtaining the peroxidase activity during the evolution of DHP
while maintaining a functional requirement as Hb. In addition, other physiological factors
likely also play a role given that human hemoglobin (a tetrameric and allosteric heme
protein [3]) has approximately 10-fold lower O2 affinity than DHP at about neutral pH.
Note that Mb itself has a dehaloperoxidase activity that is much lower (~ 8% that of DHP
at pH 5.4, with TCP as substrate [8]) than that of DHP.
One structural factor that contributes to the lower O2 affinity of DHP is almost
certainly the longer distal His Nε – heme iron distance in DHP compared to that in Mb. In
our previous study, the dehaloperoxidase activities of G65T, G65I and F43H/H64L Mb
mutants, all of which have elongated distances (by 0.3 – 1.1 Å) between distal His and
heme iron, were examined. The resulting kcat values for these mutants increased along
with the distal His Nε – heme iron distance (Table 2.1) [10]. This is consistent with the
significantly (× ~6) enhanced peroxidase activity of the F43H/H64L Mb mutants over
that of wt-Mb and may be true within a certain distance limit (< 6.6 Å, estimated based
on L29H/H64L Mb, PDB: 10FJ) as found by Watanabe and co-workers [34]. Conversely,
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the KO2 values measured in this study show the opposite trend. As shown in Table 2.1,
their O2 affinities decrease as the distal His Nε – heme iron distance increases, This is
reasonable considering the H-bond formed between the distal His and dioxygen in the wtMb might be weakened in the mutants with the distal His located further from the heme
center [13-15]. Thus, based on the present results with Mbs, we propose that “the longer
the heme iron-distal His Nε distance, the weaker the O2 affinity” co-relation exists in
general for O2-binding heme proteins when other structural and electronic factors are kept
similar. This finding (Table 2.1) in turn strongly suggests that the longer heme iron-distal
His Nε distance in DHP than in wt-Mb must have a considerable O2 affinity lowering
effect even by a factor of an order of magnitude (Table 2.1). However, to maintain its
primary function as an O2 carrier, such an unfavorable effect may need to be
compensated for DHP by altering other structural/electronic factors such as those
described below. Any such adaptations that also involve further enhancement of the
peroxidase activity would certainly be even more beneficial for DHP.
Steric Effects in the Distal Pocket
The L100F DHP variant, with the volume of the distal cavity reduced by a larger
side chain amino acid residue, was designed in our previous study as a probe of the TXP
(X = Br, Cl) substrate binding site of DHP [10]. The structure of this mutant in the ferric
state has been reported by Plummer et al. [35]. The structure of the L100F•O2 complex
shows that Phe100, which is located at the back of the cavity, does not form contacts with
the bound dioxygen molecule nor with the distal histidine (Figure 2.3 A). The increased
affinity is likely due to entropic factors resulting from the cavity volume reduction
meaning that fewer disordered water molecules need to be displaced upon O2 binding.
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Similar conclusions, based on a modeled position of dioxygen, were reached for the
I107F mutant of human and sperm whale Mbs [16, 17]. Only the subtle difference in the
turnover numbers for this mutant compared to that for the wild type enzyme suggested
that the productive binding site of substrate halophenol is not in the distal pocket [31]. It
is also interesting to test the O2 affinity of this mutant since the analogous I107F Mb
mutant has been studied as a part of unsuccessful effort to engineer high O2 affinity Mb
using Ascaris suum globin [16]. As found in this study, the effect is similar, albeit
stronger, I107F Mb has 1.4-fold higher O2 affinity than wt-Mb while L100F DHP
exhibits a 3-fold higher O2 affinity than wt-DHP (Table 2.2). Apparently, this type of
mutation would not be effective in enhancing higher O2 affinity or peroxidase activity for
DHP.
Effects of the Electronic “push” from the Proximal His89
Dioxygen affinity has been shown to positively correlate with electron density on
the heme iron [25, 33, 36] and negatively correlated with reduction potential [37]. An
electronic “push” from the proximal side toward the heme center could promote the
formation of an Fe3+-O2- -like species and thus hinder the dissociation of O2 from the
Fe2+-O2 complex. The M86E DHP mutant designed in our previous study has a negative
charge inserted near the neutral proximal His in the wt-DHP. Subsequently, Franzen and
coworkers have shown that its redox potential is considerably lowered [from 202 mV to
112 mV (vs. SHE)] compared to the wild type, confirming the increased electron density
on the heme iron of this mutant [18]. As expected, the O2 affinity for this DHP mutant
shows a significant increase by about five-fold while at the same time displaying an
approximately three-fold increase in dehalogenase activity (Table 2.2). However, DHP

!

44

did not use this mutational strategy for its functional adaptation, presumably because the
gains by this alteration may still not be beneficial enough. However, in making such an
interpretation it should be considered that this mutation was done on DHP, which has
already an adapted O2 affinity.
Effect of the Rotational Position of the Proximal His89
Comparing the heme coordination structures of DHP and Mb, a roughly 60°
rotation of the proximal His imidazole ring (Figure 2.5) has been found and is believed to
play an essential role in the peroxidase function of DHP [5, 10]. This factor might also
influence the O2 binding ability of DHP as the rotation of the proximal His has also been
seen to affect O2 affinity in heme proteins [21, 22]. One example is soybean
leghemoglobin-a (Lba) which exhibits ~20-fold higher O2 affinity than SW Mb. The
proximal His of Lba is in the “staggered” conformation in which the His plane aligns
with a line that goes through the center of the two perpendicular intersecting lines going
through two sets of diagonal pyrrole nitrogen-nitrogen. (Figure 2.7, B). In contrast, the
proximal His of SW Mb is in “eclipsed” conformation (with the His plane aligning with a
line that goes through two opposite pyrrole nitrogens) [41]. The “staggered”
conformation favors ligand binding with higher affinity than the eclipsed one via an
electronic effect [38, 39]. Therefore this 45° rotation of the proximal His in Lba
compared to that in Mb is mainly responsible for its much higher O2 affinity [21, 40-42].
H93K/T95H Mb was prepared in our previous study for the purpose of mimicking
the positioning of the proximal His in DHP (vide supra) [10]. Although its crystal
structure is not presently available, a model based on the DHP structure indicates that the
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Figure 2.5. Schematic illustration showing the heme environmental structural differences
between SW-Mb (left), DHP (middle) and HRP (right) in their O2 complexes. In this
illustration, the differences in their O2 affinities (Mb vs. DHP) and in peroxidase activities
(Mb, DHP and HRP) are shown to be correlated to the distal His to heme iron distances (black
dashed lines), proximal His plane rotations relative to the porphyrin plane (Mb vs. DHP) and
the absence (DHP)/presence (HRP) of the electron ‘‘push’’ (proximal His!heme iron) and
‘‘pull’’ (from heme iron toward distal Arg) mechanism. Cyan dotted lines indicate hydrogen
bonds. Note that the Fe-O-O bond angle in the HRP-O2 [47] complex is similar to that in the
Mb or DHP complex, but looks linear (180°) in this illustration due to the projection angle
chosen. Also note that O2 binding to ferrous HRP is essentially irreversible, i.e., HRP hemebound dioxygen is not dissociable presumably because of its interaction with the positively
charged distal Arg38 [48]. The PDB access codes for the structures of oxy-Mb, -DHP and
HRP are 1a6m, 4kjt (this paper) and 1h57 [47], respectively.
!
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proximal His in this mutant is rotated about 60o from the eclipsed conformation (Figure
2.7, C vs. A). This is a conformation that favors ligand binding with high affinity. Indeed,
this mutant exhibits ~ 20-fold higher O2 affinity than that of wt-Mb (Table 2.4), which in
turn supports the structural model for the mutant, along with ~ 50-fold increase in
peroxidase activity as reported previously [10] (see also Table 2.4). These remarkable
increases in both O2 affinity and dehaloperoxidase activity by the H93K/T95H double
mutation in Mb explain reasonably well why DHP has adapted its proximal His plane to a
position that is rotated about 60o from the eclipsed conformation (Figure 2.7, C). The KO2
data obtained in this study give more importance to this rotation, which not only
markedly increases peroxidase function but also helps maintain moderate O2 binding
affinity by sufficiently compensating for the weakened O2 affinity as a consequence of
the longer distal His Nε – heme iron distance.
Effects of Distal His-55 Flexibility: Oxygen Affinity of T56G DHP and Effects of the
Substrate TCP and Inhibitor 4-BP
As discussed above, the flexibility and location of the distal His55 in DHP are key
determinants for both O2 binding and enzymatic activity. The Thr56 adjacent to the distal
His55 is likely to affect the flexibility of the distal His, and thus we would expect to see
significant effects on the functions of DHP by changing this residue. By replacing Thr56
in DHP with much smaller-sized Gly that is found in Mb next to the distal His-64 (Figure
2.1 B), the distal His55 is expected to gain more mobility. Although we could not
crystallize this mutant and thus its crystal structure is not available, the analysis of the
molecular dynamics simulations very recently reported indicates that in T56G DHP, the
distal His is further away from the heme iron and much more flexible than in the wild
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type [43]. This might explain the ~ 3.4-fold higher kcat for this mutant than wt-DHP
(Table 2.4). With respect to the O2 affinity for this mutant, the KO2 value is ~2.4-fold
larger (i.e., the O2 affinity is lower) than that for the wild type (Table 2.4). These results
are consistent with the trend that “the longer the Fe-Nε distance, the greater the
peroxidase activity [10] and the lower the O2 affinity (this study)”.
Recently, D’Antonio and Ghiladi proposed an mechanism for TCP-triggered DHP
functional switching from oxy-ferrous globin to ferric peroxidase by H2O2 [9]. In this
study, an assumption was made that TCP triggers the functional switching by
destabilizing the bound O2 in the oxy-ferrous DHP. To test this assumption, we examined
the effect of substrate (TCP) or inhibitor (4-BP) on the O2 affinity of the wt- and T56G
DHP. As shown in Table 2.4, the addition of either 2 mM TCP or 4-BP barely altered the
KO2 of wt-DHP. However, the O2 affinity of T56G DHP becomes almost two-fold higher
and about 1.5-fold lower on addition of 2 mM TCP and 2 mM 4-BP, respectively.
The different effects of TCP/4-BP on O2 affinity of these two proteins can be
partially explained by the following spectrophotometric study probing the TCP binding
mode to ferric T56G DHP. Firstly, the binding affinity for ferric T56G DHP (pH 7.0, 4
˚C) is almost 20-fold higher than that of wt-DHP (Kd = ~ 3 µM vs. 58 µM, this study),
suggesting a different TCP binding mode in T56G DHP than in the wild type. Secondly,
while TCP binding barely affects the bound distal water ligand of the ferric wt-DHP [10],
the UV-Vis and MCD spectra of the TCP-bound T56G DHP closely resembles those of
wt-DHP•acetate complex in the ferric state (Figure 2.6), indicating an anionic oxygen
ligand instead of water. Since no carboxylate-containing amino acid groups are available
in the DHP heme vicinity as a candidate to become a heme ligand (distal side Asp54 is
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located > 10 Å away from the wt-DHP heme iron), the distal ligand in the TCP-bound
T56G DHP is perhaps the hydroxide ion stabilized by the interaction with the TCP
hydroxyl group. Such interaction between TCP and heme ligand has also been seen in the
ferric L100F DHP•TCP complex where a water molecule bound to the heme Fe is also
found hydrogen bonded to the TCP hydroxyl group [31]. Based on the above findings, we
propose that the higher O2 affinity of T65G DHP•TCP than T65G DHP observed in this
study is likely due to the hydrogen bond formed between the TCP hydroxyl group and O2
ligand, while such a hydrogen bond is absent in the wild type. Further discussion about
the likely binding modes in the substrate TCP and inhibitor 4-BP complexes of oxy- and
ferric T56G DHP and L100F DHP mutants vs. wt-DHP is found in the Supplementary
Information.
Implications of the Effects of TCP on the O2 Affinity of DHP for the Functional Switch
Mechanism
Our group previously proposed a functional switching mechanism for the conversion
of DHP from an O2 carrier to a peroxidase that is mediated by TCP radical generated by
H2O2 and a trace amount of ferric DHP in the oxy-DHP sample [7]. Subsequently,
D’Antonio and Ghiladi proposed an alternative mechanism [9], in which substrate (2,4,6TXP) binding causes a tautomerization of the distal H55 that destabilizes the bound
dioxygen and thus shifts the equilibrium towards deoxyferrous DHP. Deoxyferrous DHP
then reacts with H2O2 to form the catalytically active ferryl species Cpd II [9]. Such
reactions of ferrous heme proteins with H2O2 to yield ferryl species are known [44-46].
However, the results demonstrated in this study indicate that the binding of TCP to DHP
barely affects its dioxygen affinity, suggesting an alternative role of TCP in the functional
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switching such as a reductant. In fact, we have very recently obtained evidence that
supports our previous proposal that TCP radicals are indeed involved in the DHP
functional switching mechanism [7] (S. Sun, M. Sono, J. Du, J. H. Dawson, manuscript
in preparation).

CONCLUSIONS
Since the major Hb in the terebellid polychaete Amphitrite ornata was discovered to
also have a physiological peroxidase activity, studies of the mechanism of this globincatalyzed oxidative reaction have been the focus of much attention [8]. As determined in
this study, DHP has much lower O2 affinity than SW Mb (KO2(DHP) = 3.23 µM vs. KO2(Mb)
= 0.27 µM at 4˚C), which is reasonable because Mb functions in O2 storage while DHP
transports O2 as a coelomic Hb [1]. As schematically illustrated in Figure 2.5, we found a
trend of “the longer the distal His Fe-Nε distance, the greater the peroxidase activity
(previous study [10]) and weaker the dioxygen binding ability” (this study) for Mb. These
trends help explain the intermediate globin and peroxidase function of DHP compared to
HRP and Mb. On the proximal side of DHP, our results suggest that the rotational
position of the proximal His89 are quite essential to maintain a proper O2 affinity for its
Hb function. These results demonstrate how DHP has gained significantly enhanced
enzymic (peroxidase) capability in its evolutional process for protection from toxic living
environment without compromising its primary function as an O2 carrier.
On another aspect, destabilization of the O2 complex of ferrous wt-DHP (i.e.,
weakening of the O2 affinity) was not seen in the presence of even at millimolar
concentrations (up to 2 mM) of TCP. These results challenge the newly proposed
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peroxidase cycle for DHP by D’Antonio and Ghiladi [9] in which the oxyferrous
derivative is the starting state and the release of O2 is the trigger to activate peroxidase
activity.
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SUPPORTING INFORMATION
Binding modes for the substrate TCP and inhibitor 4-BP complexes of oxy- and ferric
T56G DHP and L100F DHP mutants vs. wt-DHP
Spectrophotometric titrations for TCP binding to ferric T56G DHP (not shown) and
wt-DHP (see [S1] for a similar titration) and spectral (UV-Vis and MCD)
characterizations of the resulting complexes suggest that the two proteins have distinct
binding modes (positions and locations) for TCP (Figure 2.6). The resulting absorption
and MCD spectra of TCP-bound ferric T56G DHP (Figure 2.6, red solid line) closely
resemble those of the acetate complex of ferric wt-DHP (at pH 5.4, black dotted line in
Figure S1) and Mb (at pH 7, blue dashed line in Figure S1), both reported previously
[S1]. Furthermore, the binding affinity for the TCP complex of T56G DHP (pH 7.0, 4 ˚C)
is found to be extremely high (Kd = ~ 3 µM, this study).
Previously, two modes of TCP binding were observed in crystallographic studies: one
“internal”, deep within the distal cavity, the other “external” with a TCP molecule
blocking access to the distal cavity and hindering ligand binding to the heme iron [S3].
Both TCP binding modes are different from the 4-XP binding mode [S4]. The TCP
binding mode observed in crystals depended on DHP mutant studied and even in some
cases was different in the subunits of the DHP dimer. On the other hand the very high
TCP concentration used, 200 mM (in 50/50 v/v water/ethanol), makes it unlikely that
another TCP binding site in the studied proteins (DHP, Y34N, Y34N/S95G and L100F)
exists [S3]. At lower concentrations, such as 2 mM, TCP binding in crystals was below
the observation threshold. TCP functions as a substrate with a KM of about 0.5 mM
because its affinity for Compound I is higher than for DHP [S3]. Similar conclusion was
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reached for Mb based on inhibition studies of its dehaloperoxidase activity by phenol
[S5]. Ferric T65G DHP has TCP affinity much higher than any other DHP variant studied
so far. It is highly unlikely that the TCP mode of binding is external because this mode
locks the dioxygen binding site while T65G oxygen affinity in the presence of TCP is
higher than in its absence. Much more plausible is that T65G DHP•TCP complex
resembles L100F DHP•TCP and wt DHP•TBP complexes in which the internal binding
mode is observed [S3, S6].
The L100F•TCP structure allows more in depth mechanistic analysis because the TCP
occupancy is high while in the reported DHP•TBP structure it is low, only 10%. In the
L100F DHP•TCP complex there is a water molecule bound to the heme Fe and hydrogen
bonded to the TCP hydroxyl. Although there is some overlap of the TCP hydroxyl
positions in L100F DHP•TCP and the position of the distal atom of the dioxygen
molecule in the reported here L100F DHP•O2 structure (Figure 2.5), only a minor
adjustment of the TCP position or tilting the O2 molecule is needed to eliminate the
hindrance. Also, the likely hydrogen bond between the hydroxyl and dioxygen can
explain the higher O2 affinity of T65G DHP•TCP than T65G DHP as observed in this
study, the assumption that the T65G•TCP complex is similar to the L100F DHP•TCP
complex would suggest a water molecule as the distal ligand in the ferric state.
[S1]

J. Du, X. Huang, S. Sun, C. Wang, L. Lebioda, J.H. Dawson, Biochemistry 50
(2011) 8172-8180.

[S2]

J. Vojtěchovský, K. Chu, J. Berendzen, R.M. Sweet, I. Schlichting, Biophys. J. 77
(1999) 2153-2174.
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C. Wang, L.L. Lovelace, S. Sun, J.H. Dawson, L. Lebioda, Biochemistry 52
(2013) 6203-6210.

[S4]

M.W. LaCount, E. Zhang, Y.P. Chen, K. Han, M.M. Whitton, D.E. Lincoln, S.A.
Woodin, L. Lebioda, J. Biol. Chem. 275 (2000) 18712-18716.

[S5]

X. Huang, C. Wang, L.R. Celeste, L.L. Lovelace, S. Sun, J.H. Dawson, L.
Lebioda, Acta Crystallogr. F Struct. Biol. Cryst. Commun. 68 (2012) 1465-1471.

[S6]

J. Zhao, V. de Serrano, J. Zhao, P. Le, S. Franzen, Biochemistry 52 (2013) 24272439.
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Table 2.5. O2 affinities of wild-type Sperm Whale Mb and DHP in 100 mM potassium
phosphate buffer (pH 7.0) at 4 °C and ~ 22 °C.

!

Protein

KO2 (µM)
4 °C, pH 7.0

KO2 (µM)
~ 22 °C, pH 7.0

WT Mb

0.27 ± 0.01

0.83 ± 0.06

DHP

3.23 ± 0.37

7.70 ± 0.45
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Table 2.6 Crystallographic data and refinement statistics for L100F DHP A-O2 complex.
DHP complex
PDB code
X-ray source
Wavelength (Å)
Number of Frames
Oscillation Range (degree)
Temperature (K)
Space group
Unit cell dimensions
a (Å)
b (Å)
c (Å)
3
Volume (Å )
Mosaicity (deg.)
Resolution range (Å)
(highest shell)a
Redundancy (highest shell)
Average I/σ(I)
Total number of reflections
Number of unique reflections
Completeness (%) (hi. shell)
Total linear R-merge (hi. shell)
R-value (%) (highest shell)
Rfree -value (%) (highest shell)
Ramachandran statistics
% of residues
In most favored regions
In additional allowed
In generously allowed
Average B factor for protein
Average B factor for solvent
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L100F•O2
4kjt
APS ID 22
1.000
180
1.0
100
P212121
59.128
67.782
68.132
273061
0.45
47.8-1.44
(1.46-1.44)
6.9 (4.7)
15.0
342270
47333
98.3 (68.9)
6.4 (33.2)
13.3 (19.0)
18.0 (26.7)
94.0
6.0
0
19.0
36.3

Table 2.7 Effects of TCP on O2 affinity of T56G DHP in 100 mM potassium phosphate
buffer (pH 7.0) at 4 °C. See the main text for the definitions of KL (isocyanide
equilibrium dissociation constant) and KP (O2/isocyanide partition constant).

[TCP], mM

0.0

0.4

0.8

2.0

!

KO2 (µM)
4 °C, pH 7.0

KL (µM) and Kp
4 °C, pH 7.0
KL

0.45 ± 0.03

Kp

17.40 ± 0.92

KL

0.46 ± 0.02

Kp

13.42 ± 0.77

KL

0.47 ± 0.02

Kp

11.92 ± 0.98

KL

0.43 ± 0.04

Kp

9.83 ± 0.82

7.83 ± 0.83

6.17 ± 0.72

5.60 ± 0.33

4.23 ± 0.52

61

!

Figure 2.6 MCD (top) and UV-Vis (bottom) absorption spectral of TCP-bound ferric
T56G DHP (red solid line, 0.8 mM TCP) in 0.1 M potassium phosphate buffer pH 7.0,
acetate-bound ferric DHP (black dotted line, 82 mM acetate) in 50 mM sodium citrate
buffer pH 5.4 (re-plotted from [S1]), acetate-bound ferric Mb (blue dashed line, 6 M
sodium acetate) in 0.1 M potassium phosphate buffer pH 7.0 (re-plotted from [S1]) and
phenol-bound ferric Lba (green solid line) (replotted from [S2]). All spectra were
recorded at 4°C.!
!
!
!
!
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!
!
!
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Figure 2.7 Proximal histidine rotational positions in (A) SW Mb, (B) Soybean
leghemoglobin (Lba) and (C) DHP. The dashed line is parallel to the plane of His ring
(which is positioned perpendicular to the porphyrin plane, i.e., the plane of this paper),
showing eclipsed (A) and staggered (B) conformations.
!
!
!

!
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CHAPTER 3

Evidence for Direct Involvement of Substrate TCP Radical in Functional
Switching from Oxyferrous O2 Carrier to Ferric Peroxidase in the Dual
Function Hemoglobin/dehaloperoxidase from Amphitrite ornata2

2

!

Sun, S., Sono, M., Du, J. and Dawson, J. H. Submitted to Biochemistry, 03/06/2014.
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ABSTRACT
The coelomic dioxygen binding hemoglobin dehaloperoxidase (DHP) from the sea worm
Amphitrite ornata is a dual function heme protein that also possesses a peroxidase
activity. Two different starting oxidation states are required for reversible O2 binding
(ferrous) and peroxidase (ferric) activity bringing into question how DHP manages the
two functions. In our previous study, the co-presence of substrate 2,4,6-trichorophenol
(TCP) along with H2O2 was found to be essential for activation of the enzymatically
inactive oxyferrous DHP (oxy-DHP) state. Based on that study, a functional switching
mechanism involving substrate radicals (TCP•) was proposed. To further support this
mechanism, herein we report details of our investigations into the H2O2-mediated
conversion of oxy-DHP to the ferric state triggered by both biologically relevant [TCP, 4bromophenol (4-BP)] and non-relevant (ferrocyanide) compounds. We also find that all
of these conversion reactions are completely inhibited by the presence of ferric heme
ligands (KCN, imidazole), indicating an involvement of the ferric oxidation state.
Furthermore, the spin-trapping reagent 5,5-dimethyl-1-pyrroline-N-oxide (DMPO)
effectively inhibits the TCP/4-BP (but not ferrocyanide)-triggered oxy- to ferric
conversion of DHP. Taken together, the results demonstrate that substrate TCP triggers
the activation of oxy-DHP into a catalytically active peroxidase through direct oxidation
by TCP radicals that are generated and start to accumulate upon H2O2-oxidation of TCP
catalyzed by trace amounts of ferric DHP initially present in the oxy-DHP sample. The
data presented herein further address the mechanism of how the halophenolic substrate
triggers the activation of hemoglobin DHP into a peroxidase.
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INTRODUCTION
!!!!!!!!Dehaloperoxidase (DHP) from the terebellid polychaete Amphitrite Ornata is a dual-

functional dioxygen-binding hemoglobin that also exhibits peroxidase activity. As the
most abundant protein in this worm [1], DHP mainly functions as an O2 carrier globin. It
is isolated in the oxyferrous state [1] and has a moderate O2 affinity (KO2) at 5.1~7.7 µM
(22 °C) [2, 3]. As a peroxidase, ferric DHP catalyzes the H2O2-dependent oxidative
dehalogenation of 2,4,6-trihalophenol (TXP) substrates to the corresponding 2,6dihaloquinone (DXQ) (where X = Cl and Br), providing A. ornata with protection against
toxic halophenols that are excreted by another inhabitant, Notomastus lobatus, in its
living environment [4, 5]. The dehaloperoxidase reaction mechanism is similar to that of
horseradish peroxidase (HRP)- or chloroperoxidase (CPO)-catalyzed oxidation that
involves two consecutive one-electron oxidations of TXP to TXP radical by two highvalent (ferryl) oxidants Cpd I/ Cpd ES and Cpd II (Scheme 3.1) [6-12]. The TXP radicals
generated in the catalytic cycle then form the final product DXQ, possibly by either
disproportionation or further enzymatic one-electron oxidation of the radicals, followed
by hydration [13, 14]. Kinetic studies have shown that at pH 5.4, DHP catalyzes
dechlorination of 2,4,6-trichlorophenol (TCP) at rates (kcat) ~33 times slower than HRP
but ~13 times faster than myoglobin (Mb) [4, 15]. The moderate peroxidase activity of
DHP arises from several structural adaptations it has acquired during its evolution from
an ancient O2 carrier with its proximal neutral histidine conserved [3, 16-18]. Besides
TXP, the much less toxic monohalophenols (4-XP) are co-present in the A. ornata
ecosystem [19, 20]. Although 4-bromophenol (4-BP) is apparently a competitive inhibitor
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Scheme 3.1. Catalytic cycle for the peroxidase-catalyzed oxidative dehalogenation of
2,4,6-trihalophenol (TXP), adapted from[6].!!
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for substrate TCP catalysis [21], it has been recently shown that 4-BP itself is also
oxidized by DHP with slow yet measurable turnover [22]. DHP has two isozyme forms,
DHP A and DHP B, encoded by two separate genes. They have very similar structures
while only differing in five amino acids [1, 23, 24]. This study will focus on DHP A.
A major question arises as to how DHP will interconvert the different oxidation
states of the heme required by these two functions, i.e., the ferrous state for the O2 carrier
role vs. the ferric state for the peroxidase activity. It has been shown that DHP can switch
from the oxyferrous state to the ferric state via H2O2-oxidation, but this only occurs when
substrate trihalophenol is present [25, 26]. The triggering mechanism has been disputed
by two research groups. Our lab has proposed a direct oxidation of the oxyferrous heme
to the ferric state by substrate TCP radicals (TCP•) that are initially generated via
oxidation of TCP by the peroxidase reaction of H2O2 in the presence of trace amounts of
ferric DHP that exist in the oxyferrous protein sample [25]. Analogous results and
mechanistic interpretations have been previously reported for the role of substrate
radicals in the conversion of lignin peroxidase compound III (non-physiological
oxyferrous state) to the active ferric enzyme [27, 28] On the other hand, Ghiladi and coworkers subsequently proposed that conversion of the ferrous state to the catalytically
active species Cpd II initiated by H2O2 replacing the bound-O2 upon substrate binding
[26]. The latter mechanism is built on the experimental observation that Cpd II can be
formed directly from deoxyferrous DHP by reaction with H2O2 alone [26]. However,
such a reaction has only been demonstrated under anaerobic conditions. With O2 bound
to the ferrous heme, Cpd II DHP can not be formed upon addition of H2O2 [25, 26]. The
lack of reactivity of oxy-ferrous DHP towards H2O2 in the absence of TXP may have
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physiological significance since DHP primarily functions as an oxygen transport protein.
The hypothesis of Ghiladi and co-workers that TCP binding triggers the formation of Cpd
II by promoting the replacement of bound O2 with H2O2 has been challenged by our
recent O2 affinity (KO2) study of DHP in which we reported that the KO2 value of DHP is
barely affected by the presence of TCP [3].
To clarify the unsettled functional switching mechanism of DHP, i.e., the H2O2mediated oxidation of oxyferrous to ferric DHP, we have further probed the role of TCP
in activating the peroxidase function from the O2-carrying ferrous state of DHP. We
have found that not only the substrate TCP and inhibitor/substrate 4-BP, but also a
structurally totally unrelated redox compound ferrocyanide, a known peroxidase substrate
[29]. can trigger the functional switch. Furthermore, we have demonstrated that the ferric
heme ligands imidazole (Im) and cyanide (CN-) as well as a spin-trapping reagent 5,5dimethyl-1-pyrroline-N-oxide (DMPO) each alone can completely inhibit the TCPtriggered conversion of oxyferrous to ferric DHP. These and additional data shown in this
study are consistent with a direct oxidation of oxy-DHP to the ferric state by TCP
radicals as the initial step in the activation of oxy-DHP for peroxidase function.
MATERIALS AND METHODS
Materials. Reagent-grade chemicals (Aldrich, ACROS, Cayman, or Fisher) were
used without further purification. HRP (type VI, Rz 2.7) was purchased from SigmaAldrich. Wild-type six-His-tagged DHP was expressed and purified as previously
described [30]. Protein concentrations were determined by the pyridine hemochromogen
method (ε555 = 34.4 M−1 cm−1) and are the concentrations of the heme component.
Homogeneous oxyferrous DHP was generated by addition of a slight excess of sodium
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dithionite to isolated DHP followed by Biogel P6DG (BioRad) desalting column
chromatography with 0.1 M potassium phosphate buffer (pH 7) at 4 °C [25].
All stock solutions of chemicals were freshly made before experiments.
Concentration of H2O2 diluted from a 30% stock solution was confirmed
spectrophotometrically (ε240 = 39.4 M−1 cm−1) [31]. TCP and 4-BP stocks (10 mM) were
made in a 50/50 (v/v) ethanol/deionized water mixture.
Stopped-Flow UV-visible Spectrophotometric Studies. Transient reactions and
the detection of enzyme intermediates were performed on a stopped-flow
spectrophotometer (1.0 cm path length, model SF-61 DX2; Hi-Tech Scientific, Salisbury,
U.K.) at 4 °C in 100 mM potassium phosphate buffer (pH 7.0) in the single-mixing mode.
The double-mixing mode has also been used only for generation of Cpd ES DHP and its
reaction with substrates: Fe(III) DHP is first mixed with 1.2 equiv. H2O2 allowing for
Cpd ES to be fully formed (age time, 15 s) and then mixed with substrates. Oxyferrous
DHP at a final concentration of 5 µM alone or containing TCP, 4-BP or ferrocyanide was
mixed with 1 or 5 equiv. of H2O2. Global analysis was performed using the Specfit
Global Analysis software and fit to exponential functions as a two-step, three species
irreversible mechanism.
Bench-top Mixing Kinetics Assays. The inhibition reactions were monitored using
a Cary 400 UV-visible spectrophotometer in a 1.0 cm path length cuvette at 4 °C. The
oxy-DHP concentration in each sample was 5 µM in 100 mM potassium phosphate buffer
(pH 7.0). The substrates (TCP, 4-BP or potassium ferrocyanide) and inhibitors (Im or
CN-) were first mixed with oxy-DHP in phosphate buffer (total volume 0.7 ml) and
incubated for 3 min in the cuvette. Subsequently, H2O2 solution (a few µl) was added to
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the cuvette to initiate the reaction.
GC-MS Analyses. A HP-5890 Restek RTX-5 GC capillary column (30 m × 0.32
mm) was used for detection of the products extracted from aqueous solution by ethyl
acetate. The initial temperature of the column was set at 50 °C for 2 min, and the
temperature was subsequently increased at a rate of 10 °C/min up to a final temperature
of 300 °C and held for 10 min. MS detection was in the electron impact (EI) ionization
mode, and a VG70S mass spectrometer scanning from 50 to 450 amu was used for
product identification.
RESULTS
TCP/H2O2-triggered conversion of oxy-DHP to the ferric state. In our previous
study, we demonstrated that conversion of oxy-DHP (5 µM) to the ferric enzyme requires
co-presence of the substrates TCP and H2O2 using excess TCP (150 µM, 30 equiv.) and 1
or 0.5 equiv. of H2O2 [25]. During the conversion, an absorption spectral change with a
single set of isosbestic points (412, 528, 592 nm) was observed, suggesting that no
detectable intermediates are involved. To further probe the conversion mechanism, we
have performed more detailed investigations in this study on the activation reaction with
[oxy-DHP]:[H2O2]:[substrate] = 1 : 1 : 1. Figure 3.1A shows that in the presence of 1
equiv. of TCP, 1 equiv. of H2O2 readily converts oxy-DHP [417 (Soret), 542 and 578 nm]
to the ferric state [407 (Soret), 503 and 635 nm] within 450 s reaction time. Under these
conditions, the spectral changes exhibit three sets of isosbestic points indicating that
another enzyme species is involved as an intermediate during the conversion.
The three sets of isosbestic point in Figure 3.1A are nearly identical to those for oxyDHP/Cpd ES (394, 586 nm), Cpd ES/ferric (414, 611 nm) and oxy-DHP/ferric DHP
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(412, 591 nm) based on overlaid normalized absorption spectra of these three DHP
species (Figure 3.6A), indicating that ferryl DHP is formed as an intermediate in the
reaction. The difference between the isosbestic point seen at 394 nm for oxy-DHP/Cpd
ES in Figure 3.6A and the actual isosbestic point at 404 nm in the time-dependent
spectral changes (Figure 3.1A) can be explained by simulated spectral changes for the
three DHP forms (Figure 3.7B) that yield a shifted (394 to 404 nm) position for this
particular isosbestic point. This shift is probably observed because of the less than
stoichiometric formation of ferryl DHP. The formation of the ferryl intermediate is also
supported by the global analysis result for the above reaction as shown in Figure 3.1B
[absorption peaks at 420 (Soret), 545 and 583 nm, green solid line], whose maximum
amount reaches only ~45% of the total DHP concentration.
Based on the above assignment, the time-dependent absorption changes at two
observed Soret isosbestic points (at 414 nm for Cpd ES/ferric DHP and 405 nm for oxyDHP/Cpd ES) could represent the time-dependent disappearance of oxy-DHP (green
diamond) and the appearance of ferric species (black circles), respectively, as shown in
the Figure 3.1A, left panel inset. These spectral changes are coupled with the rise
(absorption decrease) and decay (absorption increase) of the ferryl intermediate as
indicated by the absorption changes at 412 nm, an isosbestic point for oxy-DHP/ferric
DHP as a function of time (blue triangles in Figure 3.1A, left panel inset). A similar
result in the visible region at 591 nm was also observed for the appearance (first phase)
and disappearance (second phase) of the ferryl intermediate (blue triangles) as well as at
586 nm for the rise (absorption decrease) of ferric DHP (Figure 3.1A, right panel inset,
black circles). We have calculated the apparent rate constant (kobs) from the exponential
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Figure 3.1. (A) Spectral change upon addition of 5 µM H2O2 to 5 µM oxyferrous DHP
in the presence of 5 µM TCP. The insets in panel A show time-dependent absorbance
changes at particular isosbestic points indicated to monitor disappearance of oxy-DHP
(green diamonds), appearance of ferric DHP (black circles) and rise and decays of
ferryl (Cpd ES) DHP (blue triangles). The red bold lines on the traces show
exponential fits for the indicated time ranges and calculated apparent first-order rate
constants. (B) UV-visible spectra of oxyferrous (red solid line), ferryl (green solid
line) and ferric (blue dashed line) DHP obtained from global analysis of the data in
panel A. The inset in panel B shows the relative concentration profile determined by
the global analysis.
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part (bold red lines) of these absorption changes for oxy-DHP disappearance [(2.3 ± 0.1)
× 10-2 s-1 (A414)], ferric DHP appearance [(8.4 ± 0.1) × 10-3 s-1 (A405) or (9.4 ± 0.2) × 10-3
s-1 (A586), both considered practically identical], ferryl DHP appearance [(2.7 ± 0.1) × 102

s-1 (A591)] and ferryl DHP disappearance [(1.2 ± 0.1) × 10-2 s-1 at (A591)]. Even though

these kobs values were obtained under the non-pseudo-first-order reaction conditions, the
reaction traces nicely fit exponential decays or emergences of the three species and thus
these values can provide a convenient way to estimate the true second-order rate
constants (k) based on kobs = ~ k[TCP]o or ~ k[H2O2]o, where [TCP]o and [H2O2]o are the
initial concentrations of TCP and H2O2, respectively [32]. The kobs values thus obtained
may be useful, in evaluating the relative rates among different reactions in order to
interpret the reaction mechanisms as done in this study. Note that the rise of the ferryl
DHP species starts slowly with an apparent lag time period before its formation rate
reaches a maximum (see Figure 3.1A insets, blue triangles) suggesting that there is yet
another species is being formed prior to the formation of ferry l DHP (vide infra).
H2O2-mediated conversion of oxy-DHP to ferric DHP triggered by 4-BP or
ferrocyanide / ferricyanide. Reactions of oxy-DHP with H2O2 in the presence of 4-BP
are shown in Figure 3.2A. The maximum activation rate in the presence of excess 4-BP
(150 µM) is (2.3 ± 0.1) × 10-2 s-1, which is as fast as the conversion triggered by 1 equiv.
of TCP [(2.3 ± 0.1) × 10-2 s-1, Figure 3.1A]. In the presence of only 1 equiv. of 4-BP, the
rate is considerably slower [(6.9 ± 0.5) × 10-3 s-1, Figure 3.7A] compared with TCP by
~3.4-fold. Underivatized phenol is also able to induce the H2O2-oxidation of oxy-DHP at
a comparable rate [(3.1± 0.1) × 10-2 s-1, at 150 µM, Figure 3.7B].
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Fig. 2of 5 µM H2O2 to 5 µM oxyferrous DHP in
Figure 3.2. Spectral change upon addition
the presence of (A) 150 µM 4-BP or (B) 5 µM potassium ferrocyanide. The insets in
the top part of both panels show the time-dependent absorbance changes at selected
isosbestic points to monitor the disappearance of oxy-DHP [417 nm (A) and 414 nm
(B)], or the appearance of ferric DHP [408 nm (A) and 405 nm (B)]. The gray bold
lines on the traces show exponential fits for the indicated time ranges. Apparent firstorder rate constants (kobs) obtained from the fits are 2.3 × 10-2 s-1 (A417) and 1.9 × 10-2
s-1 (A408) in panel A and 4.8 × 10-2 s-1 (A414) and 1.0 × 10-2 s-1 (A405) in panel B.
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Surprisingly, ferrocyanide, a known peroxidase substrate[29] with a structure that is
totally different from DHP substrates, can also trigger the functional switch of oxy-DHP.
Figure 3.2 B shows that in the presence of 1 equiv. of ferrocyanide, oxy-DHP quickly
switches to the ferric state upon reaction with 1 equiv. H2O2. The spectral change for
ferrocyanide-triggered conversion of oxy-DHP is not significantly different from that for
TCP-triggered one, except that the rate is about twice greater [(4.8 ± 0.2) × 10-2 s-1 vs.
(2.3 ± 0.1) × 10-2 s-1] under the same conditions. A similar conversion has also been seen
in the presence of another structurally unrelated compound, potassium iodide (KI), but
only at acidic pH (data not shown). In fact, iodide is known to be a reductant (substrate)
for HRP Cpd I preferably at acidic pH values [12]. The apparent conversion rates, kobs
values, of oxy-DHP triggered by various substrates discussed here are listed in Table 3.1.
TCP and ferrocyanide presumably trigger the switch of oxy-DHP to the ferric state
by serving as peroxidase substrates for the trace amount of ferric DHP in the oxy-DHP
sample in the presence of H2O2. This would then generate TCP radical (TCP•) and
ferricyanide, respectively, which, in turn, would serve as an oxidant to convert oxy-DHP
to the ferric state. Thus, ferricyanide would serve the same role as TCP• in the switching
mechanism. To directly test this hypothesis, we have monitored the spectral change for
the reaction of oxy-DHP with 1.0 equiv. ferricyanide (in place of ferrocyanide) and 1.0
equiv. H2O2 as shown in Figure 3. Similar to the cases with TCP (Figure 3.1A) and
ferrocyanide (Figure 3.2B), three sets of isosbestic points are observed as shown in
Figure 3A and assigned to those for oxy-DHP/Cpd ES (586 nm), Cpd ES/ferric (414, 611
nm) and oxy-DHP/ferric DHP (412, 591 nm). Thus the change of oxy-, ferryl and ferric
DHP species can be represented by the time course traces for 611, 591 and 586 nm,
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Table 3.1. Apparent first-order reaction rate constants (kobs) for conversion of oxy-DHP
to ferric DHP triggered by various peroxidase substrates at pH 7.0, 4 °C. All rates are
determined by analyzing the time-dependent absorbance changes at 414 (TCP and
ferrocyanide) or 417 nm (4-BP and phenol) for the disappearance of oxy-DHP.
Concentrations for oxy-DHP, H2O2 and substrates are all 5 µM.
kobs (s-1)

Substrate

!

TCP

(2.3 ± 0.1) × 10-2

4-BP

(6.9 ± 0.5) × 10-3

Phenol

(3.1 ± 0.1) × 10-2

Ferrocyanide

(4.8 ± 0.2) × 10-2
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Figure 3.3. (A) Spectral change upon addition of a mixed solution of 5 µM H2O2 and 5
Fig. 3
µM potassium ferricyanide to 5 µM oxyferrous DHP for time periods of 0 – 25 s (dark
pink) and 25 – 300 s (green). (B) Time-dependent absorbance changes at particular
isosbestic points in panel A to monitor disappearance of oxy-DHP (A611, red stars),
appearance of ferric DHP (A586, blue triangles) and rise and decays of ferryl (A591, Cpd
ES) DHP (black circles). The dashed lines on the plots show exponential fits for the
indicated time ranges and calculated apparent first-order rate constants.
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respectively, as shown in Figure 3B. Different from the conversion reaction with
ferrocyanide, the reaction with ferricyanide (blue triangles) consists of a fast phase (0 25 s, enlarged in the bottom panel of Figure 3B), followed by a slow phase (75 - 300 s,
Figure 3B, top). In the fast phase (Figure 3B, bottom), ferric DHP is formed before
formation of ferryl DHP as indicated by the decrease of Abs586 to the nearly constant
value (blue triangles) vs. the little change of Abs591 (black circles for ferryl DHP) for the
first ~5 s. After ferric species stops accumulating, ferryl DHP starts to arise until it
reaches its maximum amount at the end of the fast phase (~25 s). At a later stage (75 300 s), ferryl DHP decays (black circles) concomitant with further formation of ferric
DHP (blue triangles) at a rate of ~0.008 s-1. The bimolecular rate constants for the step of
ferricyanide oxidizing oxy-DHP to the ferric state as well as for other steps involved in
the reaction above have been separately determined using a stopped-flow technique in
this study and are listed in Table 3.2 (see Discussion section).
!!!!!!!!Inhibitory effects of ferric heme protein ligands and spin trap reagent DMPO on

the functional switching of oxy-DHP. In our previously proposed functional switching
mechanism for DHP, it was speculated that the peroxidase activity of a trace amount of
Fe(III) enzyme is critical in initiating the conversion by generating TCP• as an oxy-DHP
oxidant. To further test this proposed mechanism, reagents that bind to and thereby
inhibit the activity of the ferric enzyme or that trap the TCP radicals were added to the
oxy- to ferric DHP conversion reaction. Cyanide (KCN) and imidazole (Im) are both
ferric heme ligands (Kd values for their complexes with ferric DHP at pH 7.0 and 4 °C
were ~0.5 µM for cyanide and ~0.2 mM for Im, this study) and they have much weaker
affinities for the ferrous heme proteins [e.g., Kd = 10-1 – 100 M (cyanide) [33] and 10-1 -
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Table 3.2. Bimolecular rate constants for the reactions indicated in Scheme 3.2; k1, k2 and
k4 are for the reactions of oxy-DHP with ferricyanide (k1), ferric DHP with H2O2 (k2), and
DHP Cpd II with TCP, 4-BP or ferrocyanide (k4). Apparent first-order reaction rate
constants (kobs) obtained from the time-dependence spectral change of DHP upon reacting
with various concentrations of substrates or oxidants (from 1 up to 10 equiv.) were
plotted vs. [substrate/oxidant] and the bimolecular rate constants (k1 – k4) were calculated
from the linear correlations (see Figure 3.11 for representative examples).
Substrate/oxidant

!

Rate constants (M-1s-1)
pH 7.0, 4 °C

Ferricyanide

k1

(4.6 ± 0.4) × 104

H2 O2

k2

(3.5 ± 0.1) × 104

TCP

k4

(9.4 ± 0.3) × 102

4-BP

k4

(9.7 ± 0.9) × 102

Ferrocyanide

k4

(4.4 ± 0.4) × 102

80

Figure 3.4. UV-visible spectroscopic monitoring upon addition of 5 µM H2O2 to a
mixture of 5 µM oxy-DHP and (A) 20 mM Im or (B) 5 mM KCN in the presence of 5
µM TCP during a period of 0 - 600 s and upon subsequent addition of 25 nM HRP at
time 600 s (0.005 equiv., 0.5%) during a period of 600 to 800 s. The black circles in the
insets show the plots of absorbance at 578 nm (A578) as a function of time. The black
dashed lines are straight lines drawn through the black circles and the solid line (600 –
800 s in panel A) is the fit to an exponential decay curve which yield an apparent firstorder rate constant (kobs) of 0.009 s-1.
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101 M (Im) [34] or deoxyferrous Mb at pH 7.0]. As shown in Figure 3.4, both Im (20
mM, panel A) and KCN (5 mM, panel B) are able to totally inhibit the TCP-triggered
conversion of oxy-DHP, as indicated by the absence of absorption changes at 417 nm
(Soret peak) upon addition of H2O2 and TCP to oxy-DHP (0 - 600 s). Inhibition by CNor Im was also observed in the ferrocyanide-triggered conversion of oxy-DHP (Figure
3.8). In addition, inhibition by Im can be reversed by adding a small amount of HRP
(0.5%, 25 nM), which generates TCP radicals by catalyzing the TCP oxidation by
H2O2.[4, 13] As shown in Figure 3.4A (600 - 800 s), addition of HRP results in the
transformation of oxy-DHP [417 (Soret), 542, 578 nm (red solid line)] to Fe(III)-Im DHP
complex [415 (Soret), 538 nm (red solid line)] (k = 0.009 s-1). On the other hand, addition
of HRP (0.5%, at 600 s) to the CN--inhibited oxy- to ferric DHP conversion had little
effect (Figure 3.2.4B). This is due to the fact that ferric HRP has a very low affinity for
Im (negligible binding at 20 mM, this study), but has a high affinity for cyanide [tight
binding with Kd = (2.5 – 3.0) × 10-6 M at pH 7] [35] and thus the peroxidase activity of
HRP was completely inhibited in the presence of CN- (5 mM).
Next, to directly prove the involvement of TCP radicals in the functional switch of
oxy-DHP, the spin-trapping reagent DMPO (see Supporting Information for its structure)
that potentially traps TCP radicals was introduced to the switching process. A complete
inhibition of the TCP- or 4-BP-triggered conversion of oxy- to ferric DHP by 10 mM
DMPO was observed as shown in Figure 5. Such inhibition was also observed with
increased [H2O2] to 5 equiv. (25 µM), but more DMPO (50 mM) was needed to achieve
the complete inhibition (Figure 3.9). Attempts to detect and identify the trapped product
(DMPO-TCP radical) by GC-MS were not successful, probably due to the likely low
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Figure 3.5. UV-visible spectroscopic monitoring upon addition of 5 µM H2O2 to the
mixture of 5 µM oxy-DHP and 10 mM DMPO in the presence of (A) 5 µM TCP, (B) 150
µM 4-BP or (C) 5 µM potassium ferrocyanide for a period of 0 - 420 s. The insets in
panels A and B show plots of absorbance at 417 nm (A417) as a function of time. The
inset in panel C follows the A414 and A405 as a function of time to monitor the decay of
oxy-DHP and rise of ferric DHP, respectively. The gray bold lines on the traces show
exponential fits for the indicated time ranges, which yield calculated apparent first-order
rate constants of 4.7 × 10-2 s-1 from A414 and 1.0 × 10-2 s-1 from A405.
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stability of this adduct. However, we have been able to detect a DMPO adduct of 4-BP
(m/z = 285) formed in the DHP-catalyzed H2O2-oxidation of 4-BP in the presence of
DMPO (Figure 3.10). Significantly, DMPO (10 mM) has no effect on the ferrocyanidetriggered conversion of oxy- to ferric DHP [kobs: (4.7 ± 0.1) × 10-2 s-1 (Figure 5 C) vs.
(4.8 ± 0.2) × 10-2 s-1 (Figure 3.2 B)], indicating that the DMPO inhibition on the
functional switch can be only through trapping the halophenolic radicals.
DISCUSSION
In this study, we have found that not only TCP, but also 4-BP, phenol, ferrocyanide
and KI can all trigger the H2O2-dependent activation of oxy-DHP [apparent activation
rates (kobs) listed in Table 3.1]. Since these five compounds have different structures
(especially the first three phenol derivatives vs. ferrocyanide and KI), yet all are
peroxidase substrates, i.e., electron donors, it is quite likely that rather than substrate
(TCP) binding, substrate oxidation is involved in the conversion mechanism. In
agreement with this supposition, we recently showed that addition of TCP or 4-BP (up to
2 mM, cf. Km = ~0.3 mM for TCP[36]) does not affect the KO2 values for DHP [3], thus
ruling out the possibility that TCP triggers the functional switch by binding and
modulating the O2 affinity [26]. In addition, we have shown clear evidence that blocking
the catalytic activity of the ferric component in the oxy-DHP sample (using ferric heme
ligands, Im and cyanide) also blocks the functional switch and such blockage by Im can
be reversed by HRP (Figure 3.4A) that catalyzes the oxidation of the substrate TCP to its
radical [4]. Previously, a spin-trapping reagent DIPPMO (5-diisopropoxy-phosphoryl-5methyl-1-pyrroline-N-oxide) has been reported to trap the TCP• generated from the
reaction of ferric or oxy-DHP with H2O2 in the presence of TCP as demonstrated by 31P
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NMR [26]. However, the identity of the compound formed by the trapping was not
established and the possible inhibition of the oxy- to ferric DHP or ferryl DHP
conversion by DIPPMO was not examined in that study. In the present study, we have
used DMPO as the TCP radical trap to probe the role of TCP in triggering the DHP
functional switch. The complete inhibition of the TCP/4-BP-triggered (but not the
ferrocyanide-triggered) activation of oxy-DHP by DMPO confirms the involvement of
TCP radicals in the DHP functional switch.
Based on the results from the present study on the activation of oxy-DHP as well as
our previous findings [25]. Scheme 3.2 illustrates the mechanism for the H2O2-mediated
oxidation of oxy-DHP to the ferric state in the presence of substrate TCP (as proposed
previously [25]) or ferrocyanide (newly found in this study). In the first phase, oxyferrous
DHP is oxidized to ferric DHP by TCP• or ferricyanide (with bimolecular rate constant
k1), both of which are the oxidative products gradually generated from the normal
peroxidase catalytic cycle mediated by the initial trace amount of ferric DHP present in
the oxy-DHP sample. It is most likely that TCP radical directly oxidizes oxy-DHP as
previously proposed for lignin peroxidase Cpd III (oxy-peroxidase) [28] while the
oxidation by ferricyanide occurs via the deoxyferrous form as has been shown for oxyMb [37]. During this phase, TCP• or ferricyanide oxidize oxy-DHP to the ferric state,
which subsequently forms ferryl DHP upon reacting with H2O2 in the second phase (with
bimolecular rate constant k2). In the following third/fourth phases, the ferryl DHP species
(Cpd ES and Cpd II) decay to Cpd II and ferric DHP, respectively, with bimolecular rate
constants k3 and k4. This is the stage when TCP or ferrocyanide (the product of oxidation
of oxy-DHP by TCP• or ferricyanide) reduces the ferryl DHP back to ferric state. The
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Scheme 3.2. Reaction mechanism for H2O2 converting oxy-DHP to ferric state in the
presence of TCP (green) or ferrocyanide (pink).
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values of the bimolecular rate constants k1 (for ferricyanide only), k2 and k4 have been
determined in this study using stopped-flow technique and are listed in Table 3.2.
Determination of k3 is not technically feasible because DHP Cpd ES and Cpd II are
spectrally indistinguishable. Assuming k3 > k4, the rate constants that have been
determined in this study for Cpd ES + TCP/ferrocyanide reflect the k4 instead of k3 value.
D’Antonio and Ghiladi have reported the bimolecular rate constant for the reaction of
ferryl DHP B (prepared from the oxy-form in a similar way as shown in Figure 3.9A)
with TCP to be 4.1 × 102 M-1 s-1 at pH 8 and 25 oC [26]. This value is on the same order
of magnitude as the k value (presumably k4) obtained in this study for DHP A (Cpd ES +
TCP) at pH 7 and 4 oC (Table 3.2). In the case of HRP, we have shown in a previous
study that k3 = ~ 3 × 107 M-1 s-1 >> k4 = ~1.5 × 105 M-1 s-1 for ferryl HRP-oxidation of
TCP at pH 5 [32].
As shown in Scheme 3.2, ferric DHP ligands (Im/CN-) effectively inhibit the
functional switch by blocking the formation of Cpd ES and thus the generation of
subsequent oxidative products, TCP• or [FeIII(CN)6]3-. DMPO inhibits the functional
conversion (TCP-triggered only) by trapping the TCP• that oxidizes oxy-DHP to ferric
state. In the absence of these inhibitors, this reaction cycle continues in an accelerated
fashion after the initial stage using progressively accumulated ferric DHP and
regenerated TCP/ferrocyanide.
In the proposed mechanism described above, oxy-DHP directly switches to the ferric
state without formation of any intermediate. However, in the present study on oxy- to
ferric DHP conversion (with [oxy-DHP] : [H2O2] : [substrate] = 1 : 1 : 1), a ferryl
intermediate is formed before the appearance of ferric DHP (Figures 3.1 and 3.2B). The
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apparent inconsistency can be explained using Scheme 3.2. In the beginning of the
activation reaction, TCP• (or ferricyanide) is gradually generated by the peroxidase
reaction of H2O2 (initially 1 equiv.) and ferric DHP (initially trace amount). Under such
conditions, the concentration of TCP• (or ferricyanide) is much less than [H2O2].
Consequently, the apparent rate of the initial (oxy- ! ferric DHP) phase (kobs = k1[TCP•]
or k1[ferricyanide]) is considerably slower than that of the following (ferric DHP ! Cpd
ES) phase (kobs = k2[H2O2] = 3.5 × 104 M-1s-1 × 5 µM = 1.8 × 10-1 s-1, Table 3.2). When
the (oxy-DHP ! ferric DHP) phase becomes progressively faster until it reaches the
maximum rate [2.3 × 10-2 s-1 (TCP) or 4.8 × 10-2 s-1 (ferrocyanide), Table 3.1], more than
a half of the initially H2O2 remains since 1 equiv. of oxy- to ferric DHP conversion
requires 1 equiv. of TCP• generated by consuming only 0.5 equiv. of H2O2. Therefore,
the (ferric DHP ! Cpd ES) phase (kobs = k2[H2O2] ≥ 3.5 × 104 M-1s-1 × 0.5 equiv. × 5 µM
= 8.8 × 10-2 s-1) is still faster than the first (oxy-DHP ! ferric DHP) phase (kobs = 2.3 ×
10-2 s-1, Table 3.1 ).
This explains why it is not easy to detect the first phase under the conditions we
employed in this study. Actually, what we have observed is a combination of two
sequential phases, i.e. oxy- !ferric ! Cpd ES DHP, with the former phase the ratelimiting step. As the consumption of H2O2 continues while TCP•/TCP (or
ferricyanide/ferrocyanide) keeps recycling, the third/fourth phase (ferryl ! ferric DHP,
kobs = k4[substrate]) become dominant over the second phase (ferric DHP ! Cpd ES, kobs
= k2[H2O2]) and the ferryl intermediate starts to be reduced back to the ferric state. Thus,
ferric DHP produced in the first phase is partially converted to ferryl DHP (~45% as
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shown by the global analysis in Figure 3.1B) and then generated to a ~100%
stoichiometric amount at the end of the reaction.
However, when excess [TCP] is used as in our previous study [25] ([oxy-DHP] :
[H2O2] : [TCP] = 1 : 1 : 30), the rate of the third/fourth phases (ferryl ! ferric DHP, kobs
= k4[TCP] = 9.4 × 102 M-1s-1 × 150 µM = 1.4 × 10-1 s-1) exceeds the apparent ferryl DHP
formation rate (kobs = 2.3 × 10-2 s-1, Table 3.1). As a result, the ferryl species was not
detectable and only two species, oxy-DHP and Fe(III) DHP, were observed during the
activation reaction with a single set of isosbestic points.
The first step (oxy- ! ferric DHP) in the activation reaction was not detectable in
either of the above cases. However, it could be detected when sufficiently high
concentrations of oxidant (TCP• or ferricyanide) of oxy-DHP are available. In fact, such a
situation was observed in the reaction of oxy-DHP with equal equiv. of the oxidant
ferricyanide and H2O2 (Figure 3.3), in which the kobs of the first step slightly exceeds that
of the second step theoretically (0. 23 vs. 0.18 s-1, calculated from the bimolecular rate
constants k1 and k2 in Table 3.2 under the conditions employed). We have observed a fast
phase (0 - 5 s, Figure 3.2B bottom panel) during which ferricyanide first oxidizes oxyDHP to the ferric state (0.44 s-1, blue triangles) which subsequently forms ferryl DHP
upon reacting with H2O2 (0.10 s-1, black circles) in the second phase (5 – 25 s). In the
following phase (25 - 300 s, Figure 3.2B top panel), ferryl DHP slowly decays (0.008 s-1,
black circles) along with an increase (absorption decrease) of ferric DHP (0.008 s-1, blue
triangles). This is a process indicated in Scheme 3.2 as the third/fourth phases when
ferrocyanide (recycled from oxy-DHP reducing ferricyanide) is reducing ferryl DHP to
the ferric state.
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As already mentioned earlier, a “lag” (slow-phase) time for ~25 s has been found
before the ferryl DHP formation rate reaches its maximum (right panel inset, Figure
3.1A). This observation is reasonable if we consider that the conversion reaction starts
from a trace amount of Fe(III) DHP catalyzing the formation of TCP• and gets
accelerated until it becomes maximum. On the other hand, direct oxidation of
deoxyferrous DHP (in equilibrium with the oxy form) by H2O2, as proposed by Ghiladi
and co-workers, will not explain such a “lag” period, in contrast to the case of the
reaction of oxy-Mb with H2O2, where no such lag phase is obserbed [38]. Furthermore,
such direct oxidation of deoxyferrous DHP to the ferryl state by H2O2 would not be
inhibited by the ferric heme ligands, Im or CN-. Taken together, the ferryl intermediate
observed in the H2O2-mediated oxy- to ferric DHP conversion is more likely derived
from H2O2 subsequently reacting with the initially generated ferric DHP, not from H2O2
directly reacting with ferrous DHP.
CONCLUSIONS
In this report, we have shown that the DHP functional switch from the oxyferrous
state to the ferric peroxidase active state as a peroxidase, triggered by the co-presence of
the substrate TCP and H2O2, is inhibited by the ferric heme ligands Im or cyanide as well
as by the radical trap DMPO. The present results strongly support our previous proposal
that the oxyferrous enzyme is directly oxidized to the ferric state by TCP radicals that are
generated by the peroxidase reaction of ferric DHP (initially present in a trace amount in
the oxy-DHP sample and progressively accumulating), not simply through a TCPinduced displacement of bound O2 followed by H2O2 binding. The present report further
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clarifies how this bifunctional O2 carrier hemoglobin switches to its enzymatically active
ferric state as a defensive response to the presence of toxic trihalophenol substrates.
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Supporting Information
Figure 3.6: Overlaid spectra of oxyferrous DHP/ferric DHP/Cpd ES DHP and simulated
spectra for mixture of the three using the global analysis data for their time-dependent
relative popurations in Figure 1B; Figure 3.7: Spectroscopic monitoring of the oxy-DHP
reacting with 1 eq. H2O2 in the presence of 4-BP or phenol; Figure 3.8: The KCN/Im
inhibition on the reaction of oxy-DHP with 1 eq. H2O2 in the presence of ferrocyanide;
Figure 3.9: The DMPO (50 mM) inhibition on the reaction of oxy-DHP with 5 eq. H2O2
in the presence of TCP; Figure 3.10: Mass spectrum of the 4-BP-DMPO adduct product;
Figure 3.11: Measurements for the bimolecular rate constants k1 and k2 in Table 2.
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Figure 3.6. (A) Overlaid normalized spectra of oxyferrous DHP (red), ferric DHP (blue)
and Cpd ES DHP (green). Cpd ES DHP is obtained from the reaction of 5 µM ferric DHP
with 50! µM H2O2. Arrows indicate isosbestic points. (B) Simulated time-dependent
spectra (black lines) of the mixture of the three species (shown in color, which are replotted from panel A) using the normalized relative concentrations (0 – 1.00) at various
time points for a period of 0 - 450 s in Figure 1B. Arrows indicate isosbestic points.
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Figure 3.7. Spectral change upon addition of 5 µM H2O2 to 5 !µM oxyferrous DHP in the
presence of (A) 5 ! µM 4-BP or (B) 150 ! µM phenol. The insets show the time-dependent
absorbance changes monitoring disappearance of oxy-DHP [414 nm (A), 417 nm (B)]
and appearance of ferric DHP [404 nm (A) and 408 nm (B)].
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Figure 3.8. UV-visible spectroscopic monitoring upon addition of 5 µM H2O2 to the
mixture of 5 µM oxy-DHP and (A) 5 mM KCN or (B) 20 mM Im in the presence of 5
mM potassium ferrocyanide (0 - 420 s). The insets show the plots of absorbance change
at 417 nm as a function of time with a straight red solid line drawn over the data points.
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Figure 3.9. UV-visible spectroscopic monitoring upon addition of 25 µM H2O2 to the
mixture of 5 µM oxy-DHP and 5 µM TCP in the (A) absence or (B) presence of 50 mM
DMPO (0 - 225 s). The insets show the plots of absorbance at 417 nm as a function of
time for both panels. In panel A inset, apparent first-order rate constant that is calculated
from an exponential fit (red solid line) is shown. In panel B inset, a straight red line is
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Figure 3.10. Mass spectrum of the 4-BP-DMPO adduct product extracted with ethyl
acetate after the reaction of ferryl DHP (50 µM) and 4-BP (300 µM) in the presence of
DMPO (50 mM). Ferryl DHP was generated by adding 300 µM H2O2 to ferric DHP (50
µM). The structure of DMPO and two candidates for the likely 4-BP-DMPO adduct
structures are shown.
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Figure 3.11. Measurements for the bimolecular rate constants k1 and k2 in Table 2. (A)
Plot of kobs (apparent first-order rate constants) vs. [ferricyanide] for reaction of oxy-DHP
with ferricyanide. (B) Plot of kobs vs. [H2O2] for reaction of ferric DHP with H2O2. The
kobs values (solid circles) were calculated from exponential fits for time-dependent
absorbance changes at 417 nm and 406 nm upon mixing (A) 5 µM oxy-DHP with 5, 10
and 15 µM potassium ferricyanide and (B) 5 µM ferric DHP with 12.5, 25 and 50 µM
H2O2 on a stopped-flow spectrophotometer in 0.1 M potassium phosphate buffer, pH 7.0,
at 4 °C. k1 and k2 were determined by calculating the slopes of the linear correlation as
shown in solid lines in panel A and panel B, respectively.

!

104

PART II
CHAPTER 4

Introduction to Part II:
H93G myoglobin cavity mutant as spectroscopic model of cytochrome P450

!

105

Heme-iron coordination models
Heme-iron coordination modeling has been a subject of interest for decades. It
provides valuable information for identifying newly found heme proteins and better
understanding their structure-function relationships. Earlier attempts to generate heme
coordination models has included the total synthesis of the porphyrins with the desired
ligands attached [1-4]. Although this approach resulted in several good mimics of native
heme protein active sites, the synthesis is challenging and problematic in yielding
homogenous complexes.
Another method for preparing heme models has been the use of site-directed
mutagenesis on native heme proteins. Myoglobin (Mb) is a relatively small (~15 kDa)
and simple heme protein that has been proved to be an ideal scaffold for protein
engineering. Numerous engineered Mbs have been created with improved native function
(O2 binding) or artificial enzymatic activities [5-8]. Mb has also been employed for the
preparation of heme models. Directly replacing the proximal His of Mb by Cys or Tyr
successfully generates models for P450 and catalase, respectively [9, 10]. However, only
a quite limited number of models can be prepared by this method due to the structural
constraints and folding problems found for some mutants. In 1994, Barrick established a
novel approach to prepare heme models using a H93G Mb cavity mutant. The mutant
replaces the proximal His93 with a small Gly, leaving a proximal cavity for the binding of
exogenous ligand to the heme (Figure 4.1). This simple yet creative approach has very
little limitations in generating desired heme-coordination complexes compared with
previous synthetic methods and immediately boosts the size of the heme modeling
library.
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Figure 4.1. A schematic representation for the active site of H93G Mb showing the
proximal cavity and the distal pocket where the exogenous ligands bind.
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Our lab has contributed a large array of heme coordination models as mimics of
native heme proteins with various proximal ligations [11]. For example, the imidazole
adducts of H93G Mb structurally mimics His-ligated heme proteins such as peroxidases;
the alkylamine adducts of H93G Mb spectroscopically resemble the Lys-ligated heme
proteins such as CO oxidation activator (CooA). The H93G Mb adducts can also be
studied in different iron oxidation states with addition of desired distal probing ligands
such as CO, NO or O2. All the prepared heme models have been characterized by both
UV-visible (UV-Vis) absorption and magnetic circular dichoism (MCD) spectroscopy.
MCD is highly useful as a fingerprinting technique in identifying the heme coordination
structures because it provides both positive and negative signals (and cross-over points)
as compared with only the positive features of the UV-Vis absorption spectroscopy.
Taking advantage of the versatile protein scaffold and the powerful spectroscopic
technique, we have established a large protein-based heme coordination library that
contributes valuable knowledge on structure-function relationships of heme proteins.

Cytochrome P450
Cytochrome P450 (P450) is a large family of heme-containing monooxygenase
enzymes that catalyze the insertion of one oxygen atom of O2 to organic substrates (Eq.
4.1) [12]. The name comes from the unique absorption peak at 450 nm in the ferrous-CO
state of the enzyme. P450 can be found throughout the biological kingdom with
important functions such as detoxification of xenobiotics and synthesis of signaling
molecules (e.g. hormones).
R3C-H + O2 + 2H+ + 2e- ! R3C-OH +H2O (4.1)
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The first solved structure of P450 is that of P450-CAM (CYP 101), a soluble protein
isolated from a bacteria pseudomonas putida (Figure 4.2) [13]. The protein has a
molecular mass of ~ 45 kDa consisting of a single polypeptide in an overall triangular
shape (panel A). The heme cofactor is deeply buried inside with a conserved proximal
cysteine residue that covalently tethers the heme to the protein backbone (panel B). The
anionic Cys ligated to the heme iron provide a strong electron push that facilitats O-O
bond cleavage to form the Cpd I of P450, which is the “active oxygen” intermediate that
actually oxidizes hydrocarbon substrates [14]. Figure 4.3 schematically illustrates the
whole catalytic cycle of P450 starting from a H2O-bound six-coordinate low-spin ferric
resting state (1). Upon substrate binding, the enzyme loses the distal H2O ligand yielding
a five-coordinated high-spin species (2) which is readily reduced by one electron
[provided by NADH through an electron-donor iron-sulfur protein putidaredoxin (Pd)] to
ferrous state (3). The deoxyferrous P450 then bind O2 to form the oxyferrous species (4),
which is in resonance with a ferric superoxide complex (5). One electron transferred from
NADH (via Pd) followed by protonation yield the ferric-hydroperoxide (7). The next step
is the O-O bond heterolysis facilitated by the proximal “thiolate-push” discussed above.
The resulting active species Cpd I (8) can oxidize inert hydrocarbon substrate camphor
and return to the resting state. The maintenance of the proximal thiolate ligation to the
heme iron is crucial for P450 to function.

Models for Cytochrome P450
It has been found that proximal heme environment is critical in stabilizing the hemethiolate ligation [15]. In Figure 4.4, the proximal Cys357 is in a H-bond network with the
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(A)

(B)

Figure 4.2. Front (A) and side (B) views of the structure of P450-CAM from
pseudomonas putida (pdb accessing code: 2CPP) [13]. Heme prosthetic group is colored
in green. Panel B shows substrate camphor molecule in red and the proximal cysteine
residue in yellow.
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Figure 4.3. Reaction cycle for cytochrome P450 showing the core intermediates (adapted
from reference [12]).
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Figure 4.4 Active site of cytochrome P450-CAM (CYP101) (taken from reference [16]).
A possible proton delivery network involving a series of hydrogen bonded water
molecules (the middle part of the right hand side) [31] is also shown (Protein Data Bank
code: 1DZ8).
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peptide carbonyl oxygen atoms of several adjacent residues such as Leu358, Gly359 and
Gln360. It has been of great interest to build a stable cysteinate-ligated heme structure in
other heme proteins systems. Early attempts used the approach of site-directed
mutagenesis. H93C human myoglobin, in which proximial His was replaced by Cys,
exhibits spectroscopic features that resemble those of ferric P450 as well as significantly
enhanced peroxidation activity [9]. However, upon reduction, the spectrum of ferrous
H93C Mb looked quite different from the native ferrous P450, implying the loss of
proximal thiolate ligation. In another study, the H175C/D235L yeast cytochrome c
peroxidase (CcP) double mutant was prepared with the proximal His mutated to Cys and
the nearby Asp replaced by Leu [17]. The purpose of replacing an anionic (i.e.
carboxylate) Asp235 residue with a nonpolar neutral amino acid Leu in conjunction with
His175Cys mutation is to help stabilize the negatively charged cysteinate ligation to
heme iron that favors a hydrogen bond donor rather than hydrogen bond acceptor such as
Asp. Unfortunately, the MCD spectra of this mutant also only resembled that of P450 in
the ferric but not the ferrous state.
Our lab has been using H93G Mb as a scaffold to prepare models for P450 [18, 19].
Titrations of exogenous ligand-free ferric H93G Mb with an extensive series of thiols
successfully generated mimics for ferric P450 with similar spectroscopic features.
However, as the previous studies on human Mb and CcP, attempts to reduce the iron to
ferrous state while retaining the thiolate ligand were unsuccessful. The five-coordinate
adducts of ferrous H93G Mb with neutral thiol or thioether gave a MCD spectra that were
similar in general pattern to that of five-coordinate imidazole-ligated ferrous WT Mb but
quite distinct from that of thiolate-ligated deoxyferrous P450 (Figure 4.3) [18]. This
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result suggested that the proximal cysteine thiolate might be protonated to yield a neutral
thiol upon reduction of the heme iron to ferrous state.
The difficulty in establishing a stable cysteinate-ligated ferrous heme complex like
that in ferrous P450 is proposed to be due to weakening of the Fe-S bond that is stable in
the ferric state (overall charge on the heme iron = 0), but becomes unstable upon
reduction of the iron (overall charge = -1). Thus, to create a spectroscopic model for
ferrous P450, an alternative approach would be to use a neutral ligand(s) with donor
properties similar to the cysteinate thiolate ligand. Alkyl phosphines are neutral ligands
that have been previously shown to have donor properties similar to thiolates in P450 and
related systems [20] and will be the focus of studies with H93G Mb reported herein.
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Figure 4.5 Overlaid MCD (A) and UV-Vis (B) spectra of ferrous H93G(EtSH) complex
(solid line), deoxyferrous cytochrome P450-CAM (dashed line) and deoxyferrous
myoglobin (dash-dotted line) at pH 7.0 (taken from reference [18]).
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CHAPTER 5

Mono- and bis-phosphine-ligated H93G myoglobin: Spectral models for
ferrous-phosphine and ferrous-CO cytochrome P4503

3

Sun, S., Sono, M., and Dawson, J. H. (2013) J. Inorg. Biochem. 127, 238-245.
Preprinted here with permission of publisher.
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ABSTRACT
To further investigate the properties of phosphines as structural and functional probes of
heme proteins, mono- and bis-phosphine [tris(hydroxymethyl)phosphine, THMP] adducts
of H93G myoglobin (Mb) have been prepared by stepwise THMP titrations of exogenous
ligand-free ferric and ferrous H93G Mb, respectively. Bubbling with CO or stepwise
titration with imidazole (Im) of the bis-THMP-ligated ferrous protein generated a mixed
ligand (THMP/CO or THMP/Im, respectively) ferrous complexes. Stable oxyferrous
H93G(THMP) Mb was formed at -40 °C by bubbling the mono-THMP-Fe(II) protein
with O2. A THMP-ligated ferryl H93G Mb moiety has been partially formed upon
addition of H2O2 to the ferric mono-THMP adduct. All the species prepared above have
been characterized with UV-visible (UV-Vis) absorption and magnetic circular dichroism
(MCD) spectroscopy in this study. The six-coordinate ferrous bis-phosphine and monophosphine/CO complexes of H93G Mb exhibit characteristic spectral features (redshifted

Soret/unique-shaped

MCD

visible

bands

and

hyperporphyrin

spectra,

respectively) that only have been seen for the analogous phosphine or CO-complexes of
thiolate-ligated heme proteins such as cytochrome P450 (P450) and C. fumago
chloroperoxidase (CPO). However, such resemblance is not seen in phosphine-ligated
ferric H93G Mb even though phosphine-bound ferric P450 and CPO display
hyperporphyrin spectra. In fact, bis-THMP-bound ferric H93G Mb exhibits MCD and
UV-Vis absorption spectra that are similar to those of bis-amine- and bis-thioetherligated H93G Mb complexes. This study also further demonstrates the utility of the H93G
cavity mutant for preparing novel heme iron coordination structures.
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INTRODUCTION
It is well-known that the functions of heme-containing enzymes largely depend on
the coordination structures of the iron center [1, 2]. Investigations of the iron oxidation
and spin state, the amino acids coordinated to the heme iron and the influence of the
surrounding protein environment provide key information to understand the mechanisms
of actions of the native heme enzymes [3-5]. To thoroughly study the structures and the
functions of the diverse heme enzymes, numerous heme iron model systems have been
developed. Among these approaches, the use of H93G myoglobin (Mb) cavity mutant,
pioneered by Barrick [6], provides a convenient way to generate heme coordination
models. The proximal cavity in H93G Mb, formed by replacing the His ligand with a
smaller non-coordinating Gly, allows exogenous ligands to enter into the active heme
center of Mb. Our laboratory has successfully prepared several model heme complexes of
defined structure using H93G Mb, such as H93G Mb imidazole (Im), alkylthiolate and
carboxylate adducts as mimics of native Mb, cytochrome P450 (P450) and oxyanionbound heme proteins, respectively [7-13]. The H93G Mb adducts with a phosphorusdonor ligand, however, have not been reported yet. Although phosphorus-donor ligands,
such as phosphines, are not found in native heme proteins, they have been extensively
used as structural and functional probes of hemoprotein active sites [14-19]. Compared to
CO, phosphines are more versatile in that they can serve as distal ligands to both ferrous
and ferric iron of hemoproteins.
In particular, we have shown that phosphine-ligated ferric P450 and C. fumago
chloroperoxidase (CPO), with a thiolate/phosphine ligand set, exhibit the rarely observed
unusually red-shifted Soret absorption bands that are characteristic of hyperporphyrins

!

120

[16], previously reported for thiolate-ligated ferric P450 and CPO with a bis-thiolate
ligand set [20]. This suggested that phosphines have very similar donor properties to
thiolate ligands and thus that heme adducts with proximal phosphine ligation might be
spectroscopic mimics of P450. Further, since phosphines are neutral ligands and it has so
far not been possible to bind anionic ligands such as thiolates to ferrous or ferryl H93G
Mb [13] to make H93G models for those P450 states, it seemed plausible that neutral
phosphines might serve as surrogate thiolates for the generation of ferrous and ferryl
H93G adducts with spectral properties resembling those of ferrous and ferryl P450. In
pursuit of that goal, we have in this study carried out a thorough spectroscopic
investigation of H93G Mb phosphine complexes in the ferric, ferrous and ferryl states.
Successful generation of the first H93G Mb spectral models for ferrous P450 and CPO
will be described. The data reported herein also further expand the already extensive
H93G Mb heme coordination model library.

MATERIALS AND METHODS
Materials.
Sperm whale H93G Mb was expressed and purified in the presence of 10 mM Im as
previously described [6, 9]. Im, tris(hydroxymethyl)phosphine (THMP), hydrogen
peroxide and sodium dithionite were obtained from Sigma/Aldrich. CO and O2 gases
were purchased from Natural Air Product.
Sample preparation.
Imidazole was removed from the proximal cavity of H93G Mb by means of heme
extraction and reconstitution with hemin [8]. Concentrations of ferric and ferrous H93G
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Mb samples were calculated based on ε406 = 112 mM-1 cm-1 in potassium phosphate
buffer at pH 7.0, 4 °C, which was determined using the pyridine hemochromogen method
[12, 21]. Complete oxidation of the protein heme iron is accomplished by addition of a
few crystals of potassium ferricyanide (Fluka) followed by gel-filtration column
chromatography. THMP and imidazole stock solutions were prepared by dissolving the
solid in ethanol and water respectively.
For the THMP titration experiments, incremental amounts of aliquots from stock
solutions of 1 mM to 0.5 M THMP in ethanol were added to exogenous ligand-free ferric
H93G Mb (~25 µM) or ferrous H93G Mb(~3 µM). Comparable amounts of ethanol did
not produce observable spectral changes. Kd values were determined from hyperbolic
regression fits of ligand saturation plots. All the titration experiments were conducted at
pH 7.0 and 4 °C. The complete reduction of ferric H93G Mb to deoxyferrous state was
achieved by adding solid sodium dithionite to degassed protein solutions. Bubbling CO to
the bis-THMP-bound ferrous H93G Mb generated the ferrous-CO derivative. For
imidazole titrations of bis-THMP-bound ferrous H93G Mb that had been prepared by
dithionite-reduction of the bis-THMP complex of ferric H93G Mb, a 2 M imidazole stock
solution (pH adjusted to 7.0) was used. The ferrous-O2 complex was generated at -40 °C
(in a mixed solvent, see below) in a chest freezer by addition of minimal sodium
dithionite solution to an extensively degassed ferric protein sample containing 0.5 mM
THMP followed by thorough bubbling with cold O2. The ferryl derivative was generated
from ferric H93G(THMP) Mb by adding 2.0 equivalents of H2O2 (relative to the H93G
Mb concentration).
Spectroscopic techniques.
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UV-visible (UV-Vis) absorption spectra were recorded with a Cary 400
spectrophotometer interfaced to a Dell PC. Magnetic circular dichroism (MCD) spectra
were measured with a magnetic field strength of 1.41 T by using a JASCO J815
spectropolarimeter equipped with a JASCO MCD-1B electromagnet and interfaced with
a Gateway PC through a JASCO IF-815-2 interface unit. Data acquisition and
manipulation were carried out as previously described [9]. EPR spectra were measured
with a Bruker EMXplus CW X-band EPR spectrometer using the following conditions:
microwave frequency, around 9.4000 GHz; microwave power, 0.2 mW (4.5 K) or 10 mW
(15 K); modulation amplitude, 5.0 G; and modulation frequency, 100.0 kHz. UV-Vis
absorption spectra and MCD spectra were obtained in 100 mM potassium phosphate
buffer (pH = 7.0) at 4 °C or in a cryosolvent of glycerol/0.1 M phosphate (70:30 vol/vol)
buffer at -40 °C and EPR spectra were obtained in 100 mM bicine {2-[bis(2hydroxyethyl)amino]acetic acid} buffer (pH = 7.5) at 4.5 K or 15 K.

RESULTS AND DISCUSSION
THMP binding to exogenous ligand-free ferric H93G Mb [ferric H93G(-L) Mb]and
spectroscopic characterization of the resulting complexes.
Stepwise additions of THMP to ferric H93G(-L) Mb produced spectral changes in
the Soret and visible regions with two clear sets of isosbestic points during the titration
(Fig. 1). This indicates that there are two phases throughout the ligand binding reaction.
In the first phase (Fig. 1A), adding low concentrations (0 - 0.12 mM) of THMP to the
exogenous ligand-free ferric H93G Mb led to the formation of the mono-THMP
coordinated species with THMP binding to the proximal side of the heme and involved a
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decrease in intensity of the Soret peak and an increase in absorbance around 577 nm. The
assumption that THMP binds first to the proximal side of the heme in exodenous ligandfree H93G Mb (H93G(-L) Mb) is based on our previous study on imidazole (Im) binding
to ferric and ferrous H93G(-L) Mb [12]. The preference for the proximal side for such
relatively large ligands (Im, THMP) is the result of the influence by steric hindrance by
the distal His-64. With further addition of THMP, a bis-THMP ferric H93G Mb with a
second THMP binding to the distal side of the heme was gradually formed in the second
phase. The Soret abosorption band is red-shifted from 406 nm to 415 nm. New UV-Vis
spectral features appear in the visible region that are typical of low-spin ferric heme
complexes consisting of two peaks around ~540 and ~560 nm that develop
accompanying the appearance of a second set of isosbestic points (Fig. 1B).
The titration data were analyzed using a simple biomolecular association scheme
and the plots of absorbance change vs. ligand concentration were analyzed by a
regression fit of a saturation plot (difference absorbance change vs. THMP concentration)
to a hyperbolic curve (Fig. 5.11, insets). The dissociation constant (Kd1) for THMP
binding to ferric H93G(-L) Mb is ~0.11mM and the Kd2 for THMP binding to monoTHMP-bound H93G Mb is 5.0 mM (Fig. 5.1, A and B insets, respectively). The THMP
saturation is not reached with ~10.6 mM ligand added for the second THMP binding due
to the insufficient phosphine concentration added (saturation: ~ 10.6 / (10.6 + 5.0) =
~0.68). Higher concentrations of the phosphine were not used because of the slow
autoreduction of the protein as evidenced by a gradual appearance of an absorption peak
at ~450 nm (Fig. 1B). Note that it was a purpose of this study to obtain Kd values to
confirm formation of homogeneous (i.e., ligand-saturated) complexes, but not necessarily
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Figure 5.1. UV-Vis absorption spectral changes upon titration of ferric
H93G(-L) Mb (25 µM in a 0.2-cm cuvette) with THMP in 0.1 M potassium
phosphate buffer, pH =7.0, at 4 °C. (a) Spectral change in the first phase on
addition of 0.027, 0.053, 0,11, 0.24, 0.50, 1.02 mM THMP. The dotted line
represents the last spectra in the second phase on addition of 10.61 mM
THMP as shown in figure (b). (b) Spectra change in the second phase on
addition of 1.02, 1.67, 2.97, 5.54, 10.61 mM THMP. The dash-dotted line
represents the starting spectra of exogenous ferric H93G(-L) Mb and the
dotted line represents the last spectra in the first phase as shown in figure (a).
The vertical arrows indicate the directions of absorbance changes.
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to obtain the values with statistic uncertainties. Nevertheless, reproducibility of the values
was estimated to be within +/- 10%.
Fig. 5.2 displays the UV-Vis absorption and MCD spectra of ferric H93G(-L) Mb
(dotted line) and ferric H93G(mono-THMP) Mb (solid line) at pH 7.0. Their overall
MCD band patterns are quite similar. For further comparison, previously published
spectra of mono-Im (dot-dashed line) and mono-THT (tetrahydrothiophene) complexes
(dashed line) of ferric H93G Mb [9, 22] are also overlaid in Fig. 5.2. As assigned
previously, ferric H93G(-L) Mb at pH 7 is a mixture of six-coordinated bis-water-bound
species and five-coordinate hydroxide adduct with the latter species being predominant at
pH 7.0 and exhibits a UV-Vis absorption spectrum with a Soret peak at 406 nm and a
charge transfer band at about 600 nm [22, 23]. Although the Soret region (350 - 450 nm)
MCD and UV-Vis spectral features of all these heme species are similar to each other,
their spectral line shapes in the visible region (450 - 670 nm) can be classified into two
patterns. The high spin charge-transfer visible absorption band at ~605 nm of the ferric
H93G(-L) Mb shifted to blue (shorter wavelength) upon ligation of THMP and THT,
while the Im complex shows a distinctly red-shifted band at ~630 nm. The corresponding
MCD band (trough) intensities and patterns for the two groups are also clearly
distinguishable. The red-shifted weak MCD trough (~635 nm) and mostly negative
feature (560 - 670 nm) for the Im adduct are characteristic of a six-coordinate nitrogendonor-Fe(III) heme-OH2 coordination mode. In contrast, more intense MCD features that
are both negative (troughs) and positive (peaks) in this region appear to be attributable to
a five-coordinate high spin heme as described above for H93G(-L) Mb and established
for mono-thioether-ligated heme (based on resonance Raman evidence [24]). Thus, the
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Figure 5.2. (Top) MCD and (bottom) UV-Vis absorption spectra of ferric
H93G(THMP) Mb (solid line, 1.03 mM THMP) overlaid with the spectra of ferric
exogenous ferric H93G(THT) Mb (dashed line, 21 mM THT), ferric H93G(Im) Mb
(dash-dotted line, 1 mM Im) and ferric exogenous ligand free H93G Mb (dotted line) in
0.1 M potassium phosphate buffer, pH 7.0, at 4°C. The latter three spectra are replotted
from Ref. [22].
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Figure 5.3. (Top) MCD and (bottom) UV-Vis absorption spectra of ferric H93G(bisTHMP) Mb (solid line, 17.6 mM THMP), ferric H93G(bis-Im) Mb (dashed line) in 0.1
M potassium phosphate buffer, pH 7.0, at 4 °C and ferric H93G (bis-THT) Mb (dotted
line) in 0.1 M potassium phosphate, pH 5.0. The spectra for ferric H93G(bis-Im) Mb
and ferric H93G (bis-THT) Mb are replotted from Refs. [12] and [22], respectively.
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mono-THMP adduct of H93G Mb is likely to be also five-coordinate (vide infra, the EPR
and Conclusions sections). Fig. 5.3 reveals that the UV-Vis and MCD spectra of ferric
H93G(bis-THMP) Mb adduct that was prepared by addition of 34 mM THMP to ferric
H93G(-L) Mb at once to minimize autoreduction, have band patterns that are broadly
similar to those of the previously reported ferric bis-Im H93G Mb as well as the ferric
bis-thioether (THT) H93G complexes [22] and related bis-Met-ligated heme protein or
heme-carrier mutants [24, 25].
THMP binding to ferrous H93G(-L) Mb and spectroscopic characterization of the
resulting complexes.
Titration of ferrous H93G(-L) Mb with THMP yields mono-THMP-bound ferrous
H93G Mb with the Kd value of 1.5µM (Fig. 5.12). Comparison of the UV-Vis and MCD
spectra of this ferrous H93G(THMP) species to those of the previously reported ferrous
H93G(Im) Mb [12] shows a close similarity except for a small blue shift of ~2 nm in
Soret region for the THMP complex (Fig. 5.4).
Reduction of the ferric bis-THMP H93G Mb with dithionite yielded the
corresponding ferrous bis-THMP complex. The overall UV-Vis and MCD spectra of this
adduct (Soret peak at 451 nm and a main band at 546 nm with a shoulder at ~575 nm)
resemble those of the phosphine adducts of cysteinate-ligated ferrous P450-CAM and
CPO except for some blue-shifts for the H93G Mb adduct (Fig. 5.5). In contrast, as
previously reported, phosphine-bound ferrous Mb has quite different spectroscopic
features with the Soret peak at 436 and two visible region peaks at 535 and 568 nm ([14],
this study). This is because Mb has a neutral histidine as its proximal ligand, while in
ferrous P450-CAM or CPO, the proximal ligands is a negatively charged cysteinate. The
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Figure 5.4. (Top) MCD and (bottom) UV-Vis absorption spectra of ferrous
H93G(THMP) Mb (solid line, 250 µM THMP) compared with ferrous H93G(Im) Mb
(dashed line, 2 mM Im) in 0.1M postassium phosphate buffer, pH 7.0, at 4 °C. The
spectra for ferrous H93G(Im) Mb are replotted from Ref. [12].
!
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Figure 5.5. (Top) MCD and (bottom) UV-Vis absorption spectra of ferrous H93G(bisTHMP) Mb (solid line, 34 mM mM THMP), bis-(hydroxymethyl)methyl phosphine
(BHMMP)-bound ferrous P450-CAM (dashed line) in 0.1 M potassium phosphate
buffer, pH 7.0, at 4 °C and bis- BHMMP-bound ferrous CPO (dotted line) in 0.1 M
potassium phosphate buffer, pH 6.3. The spectra for phosphine-bound ferrous P450CAM and CPO were replotted from Ref. [16].
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similarity of theferrous H93G(bis-THMP) complex to the phosphine adducts of ferrous
P450-CAM as well as CPO is noteworthy. However, the derivative-shaped MCD Soret
band of ferrous H93G(bis-THMP) Mb is 10 and 6 nm blue-shifted compared to those
features in the spectra of the corresponding ferrous P450-CAM and CPO phosphine
complexes, respectively. This is likely due to the differences in the donor properties (bisphosphine vs. phosphine/thiolate) of the two axial donor ligands.
CO, O2 and Im complexes of THMP-ligated ferrous H93G Mb.
Treatment of ferrous H93G(bis-THMP) Mb with CO yielded a stable ferrous-COH93G(THMP) Mb adduct that is again spectrally similar to parallel ferrous CO-P450CAM and CPO with Soret maximum absorption at 437 nm and a main visible region
band at 546 nm (Fig. 5.6). In contrast, ferrous-CO Mb exhibits a Soret band at 423 and
two visible bands at 542 and 579 nm [26].
Titrating the bis-THMP-bound ferrous H93G Mb with Im caused the Soret
absorption peak to shift from 451 nm to 432 nm and the main visible peak at 546 nm to
split into two peaks at 534 nm and 564 nm (Fig. 5.13). The occurrence of clear single set
of isosbestic points during the spectra change as well as the good fit of the plot of peakto-trough absorbance in the difference spectra (data not shown) vs. Im concentration to
the regression hyperbolic saturation (Fig. 5.13, inset) indicate a conversion from ferrous
bis-THMP-bound H93G Mb to a novel THMP/Im mixed ligand-coordinated ferrous
H93G derivative upon replacement of one of the two THMP ligand with Im. Further
addition of Im to this THMP/Im mixed ligand complex of ferrous H93G Mb resulted in
formation of bis-Im-bound adduct whose spectra are identical to those reported
previously [12] (data not shown). Fig. 5.7 compares the MCD and UV-Vis spectra of the
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Figure 5.6. (Top) MCD and (bottom) UV-Vis absorption spectra of ferrous-CO
H93G(THMP) Mb (solid line, 34 mM THMP), ferrous-CO P450-CAM (dashed line) in
0.1 M potassium phosphate buffer, pH = 7.0, at 4 °C and ferrous-CO CPO (dotted line)
in 0.1 M potassium phosphate buffer, pH = 6.0, 4 °C. The spectra of ferrous-CO P450CAM and CPO were replotted from Ref. [28].
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Figure 5.7. (Top) MCD and (bottom) UV-Vis absorption spectra of THMP/Im mixed
ligand-bound H93G Mb (solid line, 50 mM THMP, 400 mM Im), THMP-bound ferrous
sperm whale Mb (dashed line, 66 mM THMP) and bis-Im-bound ferrous H93G Mb
(dotted line, 4 M Im) in 0.1M postassium phosphate buffer, pH 7.0. The spectra of the
bis-Im-bound H93G Mb complex, recorded in this work, are essentially identical to
those reported previously Ref. [12].
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mono-THMP/mono-Im mixed ligand complex of ferrous H93G Mb (solid line) with
those of THMP-bound ferrous sperm whale Mb (dashed line) that was prepared in this
study. A close match of the spectra, especially in the visible region of the MCD spectra,
supports the conclusion that both spcecies have the same coordination mode of the heme
center.
Fig. 5.8 illustrates the MCD and UV-Vis spectra of the THMP-ligated oxyferrous
H93G Mb (solind line) stabilized at -40 °C. Corresponding spectra of THT/O2 complex
of ferrous H93G Mb (dashed line), oxy-Mb (sperm whale, wild-type) (dotted line) and
oxy-P450-CAM (dot-dashed line) that have previously been reported from our lab [10, 29]
are overlaid for comparison. The oxyferrous H93G(THMP) Mb exhibits MCD and UVVis spectral features that are quite similar to those of wild-type oxyferrous Mb in both
line shape and intensity, but not like those of oxy-P450-CAM, which shows relatively
weak overall MCD band intensities and a single visible absorption peak (554 nm).
These results may be attributed to the difference in the nature of CO and O2 ligands,
the former of which is a much better pi-acceptor. The differences between these two
ligands are not prominent for their complexes with the thiolate-ligated heme protein P450
(or CPO) and both the CO and O2 complexes exhibit a hyperporphyrin spectrum [30,31].
On the other hand, their (CO and O2) difference seems to be- come evident when a trans
ligand is a phosphine in their heme adducts (this study).
Phosphine-ligated ferryl H93G Mb.
Fig. 5.9A demonstrates that incubation of the ferric H93G(mono-THMP) Mb (30
µM at pH 7, 4 °C with 2 equiv. of hydrogen peroxide caused the Soret peak to shift from
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Figure 5.8. (Top) MCD and (bottom) UV-Vis absorption spectra of oxyferrous
H93G(THMP) Mb (solid line, 0.5 mM THMP), oxyferrous H93G(THT) Mb (dashed
line, 5 mM THT, replotted from [10]) at -40 oC, oxyferrous wild-type Mb at -10 oC
(dotted line; replotted from [29]) and oxyferrous P450-CAM at -30 oC (dash-dotted line;
replotted from Ref. [29]).
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Figure 5.9. (Top) UV-Vis absorption spectra of ferric H93G(THMP) Mb (a) before
(dashed line) and (b) after (solid line) addition of 36 µM H2O2 (recorded within 3 min
after H2O2 addition) and (c) the extrapolated ferryl H93G(THMP) Mb spectrum (see
text) (dash-dotted line) in 0.1M potassium phosphate buffer, pH 7.0, at 4 °C. The H93G
Mb and THMP concentrations were 30 µM and 1.03 mM, respectively. (Bottom) UVVis absorption spectrum of the extrapolated ferryl THMP-bound H93G Mb (solid line)
compared to the spectra of ferryl horse heart Mb (dashed line) and extrapolated ferryl
THT-bound H93G Mb (dotted line). The spectra were recorded in 0.1 M potassium
phosphate buffer at pH 7.0 at 4 °C. The spectrum of ferryl horse heart Mb was replotted
from Ref. [32] and ferryl THT-bound H93G Mb from Ref. [22].
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406 nm (spectrum a) to 408nm (spectrum b). The intensity of the charge transfer band at
603 for ferric H93G(THMP) Mb gradually decreases, while two new peaks at 537 and
578 nm appear. The spectral changes suggest that the ferric state is partially converted to
a ferryl complex. However, unlike the case of mono-Im-bound ferric H93G Mb (see Fig.
5.3B, dot-dashed line) ([9] and this work), the 603 nm peak in the UV-Vis spectrum
(spectrum a) did not completely disappear even after longer incubation time or treatment
with higher concentration of H2O2. Given the expectation that the ferryl derivative would
have no peak at 603 nm, it can be estimated that 40% of the ferric starting adduct
converted to the ferryl derivative. Based on this estimation, the UV-Vis absorption
spectrum of fully formed ferryl was calculated (Fig. 5.9A spectrum c). The extrapolated
spectrum thus obtained has a Soret peak at 412 and two visible peaks at 537 and 578 nm.
Compared to those of ferryl horse heart myoglobin and ferryl H93G(THT) Mb [22], the
calculated spectrum of the ferryl H93G(THMP) Mb adduct shows quite similar band
patterns (Fig. 5.9B) confirming that the extrapolation for the ferryl H93G(THMP)
spectrum is reasonable. The lower intensity of the Soret absorption and the blue shift by
10 nm are likely due to the distinctions in the donor properties of the proximal axial
ligands, phosphine vs. imidazole. The MCD spectrum for the ferryl complex of
H93G(THMP) Mb is not available due to its relatively low stability at 4 °C presumably
because the phosphine ligand in solution can serve as a reductant of the ferryl H93G Mb
species. A phosphine-ligated ferryl heme complex has not been previously described.
EPR characterization of mono- and bis-THMP-ligated ferric H93G Mb.
Ferric H93G(-L) Mb exhibits two sets of broad rhombic high spin heme iron EPR
signals at pH 7.5, 4.5 K [g-values: 6.32, ~5.65 and ~2.0 (1st set) and 6.08, ~5.85 and ~2.0
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(2nd set)] (Fig. 5.10 a). This EPR spectral feature at pH 7.5 is similar to that at pH 10.0
for H93G(-L) Mb as examined in this study [g-values: ~6.56, ~5.42, 2.0 (1st set) and 6.15,
5.82, 2.0 (2nd set), spectrum not shown]. Similarly two sets of rhombic high spin EPR
spectrum (6.89, 5.06, 1.92; 6.16, 5.84, ~2) have been observed for ferric heme complex
of the H20A (His20Ala) mutant of HmuO (bacterial heme oxygenase) at 6 K and pH 10.0,
where the heme has been shown to have a mono-hydroxide-ligated five-coordinate
structure [33]. Upon addition of a low concentration (0.2 mM) of THMP to ferric H93G(L) Mb at pH 7.5, much sharper and more intense high spin signals appeared (Fig. 5.10, b)
that apparently consist of two sets of components, one of which is rhombic and has gvalues (6.32, 5.65 and ~2.0) that are very similar to one of the two sets for the phosphinefree protein (Fig. 5.10, a). The other component showed a relatively small signal at g =
5.93. Further addition of THMP (total 10 mM) caused the rhombic signal (g = 6.32,
5.65) to diminish with the other signal (g = 5.93) intensity slightly increased (Fig. 5.10,
c). Although formation of a low spin species is expected when 10 mM THMP is added to
ferric H93G Mb (see Figs. 1b and 3), low spin EPR signals were only observed when
temperature was raised to 15 K (Fig. 5.10, d) yielding a set of g-values at 2.97 and 2.26
(the third, smallest, g-value was not detectable). These values were similar to the
corresponding low spin g-values of 3.05 and 2.22 of imidazole-bound ferric
dehaloperoxidase from Amphitrite ornata [34, 35], a His-ligated heme protein, that was
examined in the same series of experiments in this work.
To further analyze the two sets of the high spin signals (Fig. 5.10, b and c), attempts
were made to deconvolute the overlapping spectra into two-component spectra.
Somewhat unexpectedly, the rhombic signal was separated from the other one by simply
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Figure 5.10. EPR spectra of Fe(III) H93G(-L) Mb (a), + 0.2 mM THMP (b), + 10 mM
THMP (c and d) at 4.5 K (a – c) and 15 K (d). Spectra (e) and (f) are isolated
(deconvolved) rhombic (e) and axial (f) high spin heme components of mono- (e) and
bis-THMP-bound (f) Protein. The Y-axis positions for spectra a – f are arbitrarily offset
for clarity. The relative signal intensities for b and c are proportional to their actual
magnitudes, but the intensity for a has been enlarged by 7.5 times. See text for further
descriptions.
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subtracting 70% of spectrum (c) from spectrum (b) to generate spectrum (e) (Fig. 5.10e,
dashed line). Conversely, the second signal was isolated by subtracting 30% of spectrum
(b) from spectrum (c) (Fig. 5.10 f, dot-dashed line). These results demonstrate that the
first set of signals decreased by a factor of ~3.3 (100/30), i.e., by ~ 70%, while the second
set increased by ~1.4-fold (100/70) upon the increase in THMP concentration. Thus, the
two sets of signals seen in spectrum (b) arise from two separate high spin heme species.
The data also reveal that the g = 5.93 signal belongs to a high spin heme iron with axial
symmetry (f). The rhombic heme may be assigned to the mono-THMP-bound (fivecoordinate) H93G Mb. In an analogous case, mono-Met-ligated heme in the ferric
H229A HtsA (a heme carrier protein) has been shown to contain a five-coordinate heme
(based on resonance Raman evidence) and to exhibit a rhombic (along with an axial) high
spin EPR spectrum [24].

Furthermore, the bis-Met-ligated low spin-type heme in

R98C/H102M cytochrome b562 at pH 4.8 has exhibited a minor but sharp axial high spin
signal (g = 5.9) together with the main low spin signal (g = 3.16, ~2.25) [25]. The
authors attributed this signal (g = 5.9) to a probable artifact of freezing. The same
explanation may be applicable to the present result with bis-THMP-ligated H93G Mb
(Fig. 5.10, b and c). In fact the increase in the intensity of the g = 5.93 signal (by ~1.4
times) is significantly less than expected (~3.3-fold) if it is assigned as a high spin
component of the bis-THMP adduct formation. Nevertheless, the likelihood that the g =
5.93 signal originated from the bis-THMP ligated H93G Mb heme cannot be totally
dismissed. The presence of a small shoulder at ~615 nm in the UV-Vis absorption
spectrum of this complex at 4 °C may suggest that it is not completely low spin. In
summary, in this study we have obtained the rhombic EPR spectra of both high spin
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mono-THMP-ligated and low spin bis-THMP-ligated ferric H93G Mb.

To our

knowledge, this represents the first EPR characterization of high and low spin ferric heme
protein derivatives exclusively ligated by phosphines.

CONCLUSIONS
Over the past four decades, numerous heme iron model complexes has been
prepared and characterized in an effort to develop a better understanding of the
mechanism of action of native heme-containing enzymes. A large variety of ligands have
been investigated to generate complexes that mimic the active site of native hemoproteins
[7-13]. However, phosphines, although used as probe ligands, have never been studied as
proximal heme iron ligands. Phosphines bind to the distal binding site of heme proteins to
yield mixed-ligand complexes that display characteristic spectroscopic features [30]. In
this paper, a novel heme complex with phosphine as a proximal ligand has been
generated and spectroscopically characterized. The generation and characterization of a
large set of heme-phosphine complexes substantially expands the spectral database of
heme coordination structures.
As shown in Scheme 1, ferric and ferrous mono- (e and c) and bis-phosphine ligated
H93G Mb complexes (d and g) have been prepared by THMP titration of exogenous
ligand-free H93G Mb (a and b). The ferric H93G(THMP) Mb adduct is assigned to be a
five-coordinate species by analogy to the mono-Met-ligated H229A mutant of the HtsA
heme carrier protein (whose wild-type counterpart has a His/Met-ligated six-coordinate
structure heme) [24] as well as mono-THT adduct of H93G Mb [22] footnote 1. The lack of
a distal side water axial ligand in the mono THMP- and THT-ligated ferric H93G Mb
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Scheme 5.1. Mono- and bis-THMP-ligated ferric and ferrous H93G Mb generated and
examined in this work. Species d was not isolated but is proposed as an intermediate in
the formation of e upon binding of mono-THMP to a, where a and e may be in
equilibrium with e being a predominant species.!
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adducts, in contrast to the mono-Im/H2O six-coordinate complex [6, 9], is most likely due
to non-optimal (too long) distances between the heme iron and the distal histidine (His-64)
in the former two H93G Mbs. Proper distance are required for the distal His to form a
hydrogen bond to hem iron-ligated water and thus to form a water-bound six-coordinate
ferric heme complexes (for example, Mb (six-coordinate) vs. HRP (five-coordinate)).
The ferric bis-THMP adduct exhibits spectral features similar to those of H93G Mb
ligated with two identical neutral ligands such as bis-Im and bis-THT. The ferrous
H93G(THMP) Mb has spectra that are nearly identical to those of ferrous H93G(Im) Mb.
Interestingly, the UV-Vis and MCD spectra of six-coordinate ferrous phosphine
bound H93G Mb show similarities to those of corresponding P450-CAM and CPO
derivatives: i.e., ferrous H93G(bis-THMP) Mb is spectrally similar to ferrous phosphineligated P450-CAM and corresponding CPO while ferrous CO-H93G(THMP) (h)
spectrally resembles ferrous CO-P450-CAM and ferrous CO-CPO. To our knowledge,
this is the first reported non-thiolate-ligated heme model that exhibits spectral features
comparable to those of thiolate-ligated hemoprotein complexes in the ferrous state. Since
these unique spectral features were seen Cys/phosphine and Cys/CO complexes [27], but
not for the Im/THMP (i) and Im (His)/CO adducts (e.g., ferrous-CO H93G(Im) Mb [6,
9]), such spectral uniqueness of the bis-THMP (g) and THMP/CO (h) derivatives of
ferrous H93G Mb might be attributed to the difference(s) between these bases, Cys and
THMP (alkylphosphine)] vs. Im as donor ligands. A most likely factor to explain such
differences would be the much better nucleophilic (i.e., sigma-donor) nature of Cys
thiolate and phosphines (phosphorous analog of amines) compared with Im (or amines).
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Furthermore, a phosphine/Im mixed-ligand-bound H93G Mb adduct (i) that has
been generated and spectroscopically characterized serves as a model of phosphinebound sperm whale Mb. Ferryl H93G(THMP) Mb can be partially formed as previously
reported for ferryl H93G (thioether, THT) Mb and their calculated UV-Vis spectra for
homogenous ferryl species are quite similar. This is the first detailed study of the H93G
Mb cavity mutant with phosphine as the axial ligand including the new ferrous-CO and
ferrous-O2 adducts and the results again demonstrate the capacity of the H93G Mb to
serve as an extremely versatile scaffold for the preparation of a wide variety of heme
coordination structures.
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Footnote 1

: In a previous study on THT binding to ferric H93G(-L) Mb, we speculated that

the mono-THT-bound protein is a six-coordinate species with THT and hydroxide as
axial ligands [22]. However, since publication of that paper, we have become aware that
an analogous mono-Met-ligated heme protein, H229A HtsA, with UV-Vis absorption and
MCD spectra essentially identical to those of H93G(THT) Mb had been definitively
characterized as a five-coordinate heme species using resonance Raman spectroscopy
[24]. Thus, we now believe that the mono-THT-H93G Mb adduct also has a fivecoordinate heme.
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SUPPORTING INFORMATION
Figure 5.11. Difference spectra of the THMP titrations of ferric H93G Mb. Insets show
the hyperbolic regression fit (solid line) of saturation plots (closed circles) for THMP
binding to (top) exogenous-free ferric H93G Mb and (bottom) mono-THMP-bound
H93G Mb. Absorbance changes from the peak to trough in difference spectra (ΔΔA437-406
= ΔA437- ΔA406 , ΔΔA432-424 = ΔA432 - ΔA414) are plotted as a function of total THMP
concentration.
Figure 5.12. UV-Vis spectral change on the titration of exogenous ligand free ferrous
H93G Mb (3 µM in a 1 cm cuvette) with THMP in 0.1 M potassium phosphate buffer,
pH 7.0, at 4°C. Vertical arrows indicate the directions of absorbance change upon
addition of 0.78, 1.57, 3.92, 7.84, 15.69, 31.37 µM THMP. Hyperbolic saturation plot
(solid circle) and its regression fit (solid line) of the titration data is shown in the inset
where absorbance change at 429 nm is plotted as function of free (= total minus proteinbound) THMP concentration (0.39, 0.78, 1.73, 5.14, 12.82, 28.45 µM, respectively).
Figure 5.13. UV-Vis spectra change on the titration of bis-THMP-bound ferrous H93G
Mb (50 mM THMP) with Im in 0.1 M potassium phosphate buffer, pH 7.0, at 4 °C.
Vertical arrows indicate the directions of absorbance change upon addition of 2.25,
11.21, 22.30, 44.10, 86.30, 165.46 mM Im. Hyperbolic saturation plot (solid circle) and
its regression fit (solid line) of the titration data are shown in the inset, where the peak-totrough absorbance change in difference spectra (not shown) (ΔΔA433-454 = ΔA433 - ΔA454 )
is plotted as function of total Im concentration.
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Figure 5.11!
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Figure 5.12!
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Figure 5.13!
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